https://www.takeda.com/ 2023-08-03 daily 1.0 https://www.takeda.com/newsroom/newsreleases/2023/takeda-announces-the-submission-of-its-corporate-governance-report-to-the-tokyo-stock-exchange/ 2023-08-03 daily 0.9 https://www.takeda.com/science/research-and-development/ 2023-08-03 daily 0.9 https://www.takeda.com/contact-us/ 2023-08-03 daily 0.9 https://www.takeda.com/newsroom/newsreleases/2023/takeda-to-hold-1st-quarter-of-fiscal-year-2023-earnings-call-on-july-27/ 2023-08-03 daily 0.9 https://www.takeda.com/investors/overview/ 2023-08-03 daily 0.9 https://www.takeda.com/investors/newsletter/ 2023-08-03 daily 0.9 https://www.takeda.com/newsroom/newsreleases/2023/the-new-england-journal-of-medicine-publishes-data-from-phase-2-study-of-first-oral-orexin-receptor-2-agonist-TAK-994-in-patients-with-narcolepsy-type-1/ 2023-08-03 daily 0.9 https://www.takeda.com/careers/ 2023-08-03 daily 0.9 https://www.takeda.com/investors/financial-results/quarterly-results/ 2023-08-03 daily 0.9 https://www.takeda.com/hcps/ 2023-08-03 daily 0.9 https://www.takeda.com/newsroom/newsreleases/2023/takeda-reports-strong-first-quarter-fy2023-results-driven-by-growth-and-launch-products/ 2023-08-03 daily 0.9 https://www.takeda.com/worldwide/ 2023-08-03 daily 0.9 https://www.takeda.com/investors/financial-highlights/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/gastroenterology/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/pdt/ 2023-08-03 daily 0.9 https://www.takeda.com/patients/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/vaccines/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/rare-diseases/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/neuroscience/ 2023-08-03 daily 0.9 https://www.takeda.com/science/areas-of-focus/oncology/ 2023-08-03 daily 0.9 https://www.takeda.com/our-impact/our-stories/integrating-data-sciences-into-clinical-development/ 2023-08-03 daily 0.8 https://www.takeda.com/jp/careers/ 2023-08-03 daily 0.8 https://www.takeda.com/science/areas-of-focus/ 2023-08-03 daily 0.8 https://www.takeda.com/newsroom/media-resources/ 2023-08-03 daily 0.8 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/annual-integrated-report/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/stock-information/ 2023-08-03 daily 0.8 https://www.takeda.com/en-us/what-we-do/patient-services/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2017/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results/shire-financial-results/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/contact/ 2023-08-03 daily 0.8 https://www.takeda.com/worldwide/saudi-arabia/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2018/ 2023-08-03 daily 0.8 https://www.takeda.com/about/corporate-governance/charters-and-reports/ 2023-08-03 daily 0.8 https://www.takeda.com/our-impact/our-stories/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2019/ 2023-08-03 daily 0.8 https://www.takeda.com/privacy-notice/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2012/ 2023-08-03 daily 0.8 https://www.takeda.com/our-impact/our-stories/harnessing-science-to-push-the-boundaries-of-whats-possible/ 2023-08-03 daily 0.8 https://www.takeda.com/jp/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2013/ 2023-08-03 daily 0.8 https://www.takeda.com/science/research-and-development/partnerships/ 2023-08-03 daily 0.8 https://www.takeda.com/worldwide/asia-pacific-pte-ltd/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2014/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2015/ 2023-08-03 daily 0.8 https://www.takeda.com/about/corporate-governance/strategy/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2016/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2020/ 2023-08-03 daily 0.8 https://www.takeda.com/ko-kr/ 2023-08-03 daily 0.8 https://www.takeda.com/newsroom/press-releases/ 2023-08-03 daily 0.8 https://www.takeda.com/science/clinical-trials/pre-approval-access/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2021/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/events/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/financial-results/quarterly-results-2022/ 2023-08-03 daily 0.8 https://www.takeda.com/our-impact/our-stories/pursuing-life-transforming-science/ 2023-08-03 daily 0.8 https://www.takeda.com/science/pipeline/ 2023-08-03 daily 0.8 https://www.takeda.com/investors/sec-filings-and-security-reports/ 2023-08-03 daily 0.8 https://www.takeda.com/ko-kr/newsroom/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/kepedulian/obat-obatan-bagi-dunia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/who-we-are/corporate-philosophy/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/work-philosophy/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/onkologia/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/covid-19-vaccine/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/proceso-de-descubrimiento-de-medicamentos/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/peninggalan/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/maladie-de-crohn/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/nasze-historie/stories/kluczowe-elementy-w-sercu-naszych-innowacji/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/corporate-responsibility/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/talento/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/progress/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/innovatie/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/areas-of-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/innovation/quality-at-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/universal-health-coverage-and-the-power-of-people-side-event/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wie-we-zijn/takeda-nederland/onze-waarden/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/hikari/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/who-we-are/takeda-v-cr/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/disclaimer/privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/oncologia/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/droits-de-lhomme/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/jobb/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/earthquake/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/vaccines/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/areas-of-focus/gastroenterology/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/therapeutic--areas/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/kas-ms-esam/kontakti/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/inovcijas/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/produzione/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/research--development/ecosystem-for-health-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/corporate-philosophy/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/kariera-w-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/progress/report/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/innovatie/takeda-anticipeert-op-de-toekomst-met-innovaties/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/what-we-do/delivering-for-patients-with-gi-conditions/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/onkoloji/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/media/Media_about_us/2022/Interview_S_Salykhova/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/Dia-Mundial-Linfoma/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/who-we-are/--/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/hcps/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unternehmerische-verantwortung/transparenz/arzte--und-gesundheitsorganisationen/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/who-we-are/company-information/about-takeda-taiwan/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/research--development/-/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/realizing-sustainability-in-health-systems/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/sitemap/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/entyvio/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/profissionais-da-saude/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/as-nossas-historias/inovacao/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/was-wir-tun/therapiegebiete/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/foretagsansvar/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/partners/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/reflux-gastro-sophagien/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/duyarllk/bitki-ceitliliini-korumak/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/stories/die-schlusselelemente-im-herzen-unserer-innovationen/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/soins/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/research--development/clinical_trial_transparancy/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/vacunas/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/produkter/bivirkninger/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/three-stories-of-crisis-action-and-putting-patients-first/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/wer-wir-sind/company-information/240jahretakeda/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/produkter/reseptpliktige-legemidler/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/innovazione/innovazione-e-sistema-sanitario/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/areas-foco/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/produkter/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/tanggung-jawab-perusahaan/kegiatan-csr/kunjungan-ke-yayasan-karya-kasih/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/conditions-generales/ 2023-08-03 daily 0.7 https://www.takeda.com/science/research-and-development/partnerships/public-private-partnerships/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/areas-of-focus/neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/datenschutzerklarung/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/2/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/newsroom/news-releases/2022/takeda-provides-update-on-operations-in-russia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/rare-diseases/haematology/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/terms-and-conditions/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/nos-histoires/soins/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/our-business/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/gastroenterologie/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/onkologi/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/lo-que-hacemos/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/wer-wir-sind/unser-unternehmen/die-lehre-bei-takeda-neuenburg/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/corporate-responsibility/corporate-citizenship-activities/global-csr-program/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial-disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/sobre-nos/Eventos_Institucionais/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/as-nossas-historias/tradicao/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/who-we-are/icc/explore-the-facility/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/areas-foco/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/who-we-are/takeda-pricing-philosophy/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/5-edicao-da-newsletter-takeda-o-valor-do-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/contact/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/contact_us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/responsabilidad-social-corporativa/responsabilidad-social-corporativa/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/patients/siori/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/all-stories/stories/las-claves-para-envejecer-con-excelencia/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/mantelzorg-vriendelijk/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/--/6/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/helping-canadian-patients/onepath-assistance-program/ 2023-08-03 daily 0.7 https://www.takeda.com/et-ee/kontaktid/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/quienes-somos/filosofia-corporativa/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/who-we-are/message-from-the-gm/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/-/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/--/5/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/impresszum/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230727_8393/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/disclosure/medical2019/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/statement/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/nos-collaborateurs/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/allgemeine-geschaftsbedingungen/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/briga/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/who-we-are/company-information/histoire/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/erica/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/lung-cancer/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/takeda-talks/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/presse/nyheter/2022/arendalsuka-2022-hvorfor-krever-norge-et-av-verdens-rikeste-land-de-laveste-legemiddelprisene-i-europa/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/csontritkulas/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/wer-wir-sind/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/nasze-historie/innowacje/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/canadianRDinitiatives/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/who-we-are/company-information/bulding-trust/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/ko-ms-daram/medicnas-specilistiem/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/hemofilija/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unternehmerische-verantwortung/transparenz/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/dexilant/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/newsroom/news-releases/2023/INESSS-recommends-LIVTENCITY-maribavir-for-public-reimbursement-in-Quebec/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/who-we-are/company-information/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/who-we-are/our-people/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/gaucher-disease/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-Hans-Zissow-Senior-Business-Partner-Tender-Lead/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/--/2/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/areas-of-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/partners/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/who-we-are/company-information/positions--guidelines/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/vallalati-felelsseg/tarsadalmi-felelssegvallalas/ 2023-08-03 daily 0.7 https://www.takeda.com/science/research-and-development/partnerships/iir/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/research--development/investigator_initiated_sponsored_research/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/fraudulent-job-offers/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/myelome-multiple/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/werken-bij/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/share_your_warmth/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/wer-wir-sind/unser-unternehmen/takeda-in-der-schweiz/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/tietosuojailmoitus-haittavaikutusraporteille-tuotevirheilmoituksille-ja-laaketieteellista-tietoa-koskeville-pyynnoille/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Samfunnsansvar/samfunnsansvar/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/MaladiesRares/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/adhd-webbinarium-2020-06-09/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/nous-joindre/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/investors/overview/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/pessoas/junte-se-a-nos/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unternehmerische-verantwortung/transparenz/patientenorganisationen/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/--/12/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/carrieres/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/politica-de-privacidad/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/innovation/quality-at-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/responsabilite-sociale/notre-engagement/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/Oncologie/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/newsroom/news-releases/2022/takeda-continues-to-support-patients-in-russia/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/produktion/produktsicherheit/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/kontakt-oss/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/what-we-do/products/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/rare-diseases/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/newsroom/2023/pharmaindustrie-4.0-durch-innovationsgeist-und-digitalisierung-mitgestalten 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/research--development/clinical_trial_transparancy/ 2023-08-03 daily 0.7 https://www.takeda.com/science/research-and-development/partnerships/t-cira/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/samarbejde-med-patientforeninger/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/transparencia/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/presse/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/all-stories/stories/las-claves-para-envejecer-con-excelencia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/who-we-are/our-people/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/what-we-do/takedas-ordbok/takedaism/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/grij/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/pacientes/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/responsabilite-sociale/Subventions-dons-et-commandites/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/almedalen-2019-innovation-som-mojliggorare-for-okat-varde-inom-sjukvarden/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/what-we-do/plasma-made-in-austria/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/produkty/lekasky-informani-servis/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/yenilik/takedada-kalite/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/caring/plant_diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/takedada-hayat-var/takedada-mutluluk-var/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/politica-de-privacidade/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/yenilik/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/unete-a-nosotros/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/corporate-responsibility/transparency/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/urologia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/pessoas/o-que-procuramos/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/feed/oncologia/takeda-lanca-curso-de-e-learning-linfomas-de-celulas-t/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/pipeline-e-prodotti/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/acerca-de-takeda/gobierno-corporativo/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/Produktai/Receptiniai/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/compliance/CRM-Privacy-Notice/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/carrieres/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-careoncology/multiple-myeloma/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/critical-care/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/safety/reaction/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/ledelsen/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/engagement/arzneimittel-fur-die-welt/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/csr--vietnam-team-2017/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/who-we-are/press-release/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/supporting-global-covid-19-response/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/replagal/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/contacto/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/research--development/cockpi-t/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/nos-collaborateurs/diversite-equite-et-inclusion/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/corporate-responsibility/csr/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/magasvernyomas/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/takeda-australia-legal-note/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/die-reise-eines-patienten-durch-die-welt-von-takeda-osterreich/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/korporatyvna-etyka/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/co-robimy/produkty/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/as-nossas-historias/stories/os-elementos-chave-no-coracao-da-nossa-inovacao/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/herencia/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/une-enune-entreprise-responsable/transparence/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/supppliers/supplier-code-of-conduct/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/un-azienda-responsabile/takeda-al-fianco-delle-istituzioni/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/innovation/quality-at-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/corporate-responsibility/covid-19/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/who-we-are/icc/benefits/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/who-we-are/Takeda_Kazakhstandagi/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/distr/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/Birlesme-suretiyle-devralmasi/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/research--development/ecosystem-for-health-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/nos-histoires/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/our-stories/caring/ibd/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/wspolpraca/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/evi/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/newsroom/notice/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/gastroenteroloji/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Jouw-gezondheid/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/who-we-are/company-information/---/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/samarbejdsaftaler/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/corporate-responsibility/global-sosyal-sorumluluk-programlarmz/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/briga/korienje-inicijative-zaposlenih-u-otkrivanju-stanja-u-kome-se-nalaze-pacijenti/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/responsabilite-sociale/dons-de-produits/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-maria-nyman/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/ematologia-rara/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/adatvedelmi-tajekoztato/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/supppliers/supplier-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/hodgkins-lymphoma/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/who-we-are/building-trust/interactions-with-patient-organizations/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/recruitment/career/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/oncologie/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/company-information/history/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/siapakah-Kami/pt.-takeda-indonesia/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/rare-disease-day-2023/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/office/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/corporate-responsibility/ethics-and-compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/soins/des-medicaments-pour-le-monde/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/who-we-are/sveikatos-prieziuros-specialistu-bendrasis-privatumo-pranesimas/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/maladie-de-gaucher/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/recruitment/dei/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/system/privatumo-politika/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/Erfgoed/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/a-promessa-das-1000-garcas-de-origami/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/responsabilite-sociale/covid-19/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/research--development/investigator_initiated_sponsored_research/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/stories/elemen-kunci-dalam-inti-inovasi-kami/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/research-development/1/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/produkty/zoznam-produktov/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/produkty/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-care-gastroenterology/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/supppliers/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/tdah/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/farmakovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/qui-sommes-nous/gestion-des-risques-et-des-crises/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedarikcidavraniskurallari/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/sporg-om-medicin-og-bivirkninger/lagemidler-med-uddannelsesmateriale/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/worldwide/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/gastroenterology/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/solidaridad/medicamentos-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/global-ethics--compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/hjernehelse/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2022/takeda-canada-et-pentavere-research-group-discutent-du-defi-de-linnovation-de-takeda-canada/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/ma-transparency-reporting/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/our-medicines/medications-return-program/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-pacientes/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/feed/corporate/takeda-nomeada-top-employer-2022/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/hunter-syndrome/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/what-we-do/products/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/ 2023-08-03 daily 0.7 https://www.takeda.com/science/research-and-development/partnerships/tdv/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/charte-de-linformation-promotionnelle/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/suppliers/pharmaceutical-supply-chain-initiative/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/corporate-responsibility/giving-back-to-the-community/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/odpovednost/socialni-odpovdnost-v-eske-republice/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/empowering-ethnic-minorities-to-improve-health-in-myanmar/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/hcps/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Samfunnsansvar/samfunnsansvar/Samarbeidspartnere/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/ocenka_truda/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/nos-partenariats/ 2023-08-03 daily 0.7 https://www.takeda.com/newsroom/newsreleases/2020/takeda-announces-fy2020-q1-results--confirms-management-guidance--raises-reported-operating--profit-and-reported-net-profit-for-the-full-year/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/chi-siamo/politica-ambientale-di-sicurezza/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/wer-wir-sind/takeda-in-deutschland/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/research--development/our_pipeline/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/what-we-do/our-products/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/bize-ulasin/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2022/best_employers/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/vitrum_podari_zhizn/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/what-we-do/manufacturing/linz3/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/turbota/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/who-we-are/company-information/about-takeda-hongkong/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/iniziative/raro-chi-trova/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/palaute/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/bolstop/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/solidaridad/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/alunbrig/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/etablierte-produkte/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/adcetris/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/osteosarcoma/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/genetik-hastalklar/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/what-we-do/common-problem/faq-for-the-website/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/ulcerative-colitis/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/mage--tarmsykdommer/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/quem-somos/takeda-brasil/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mexico/innovation-capability-center-mexico/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/nos-collaborateurs/Travail/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/disclosure/patient/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/aktualnosci/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/fabry_disease/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/Sta-mi-radimo/proizvodi2/zdravstveni-radnici/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/stories/les-elements-cles-de-notre-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/nos-histoires/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/termos-e-condicoes-de-utilizacao/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/who-we-are/company-information/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/access_to_medicines/clinical_trials/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/newsroom/press-releases/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/announcements/2023/takeda240th-4/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/who-we-are/contactanos/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/who-we-are/company-information/company-facts/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/newsroom/news-releases/2023/national-urban-league-and-takeda-partner-on-a-new-community-based-national-initiative-to-advance-health-equity/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/turbota/using-immersive/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/corporate-responsibility/takeda-volunteers/ 2023-08-03 daily 0.7 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/gradimo-poverenje/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/who-we-are/company-information/zusammenarbeit-mit-patientenorganisationen/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/recruitment/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/research-development/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/syndrome-de-lintestin-court/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/contacts/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/hereditary-angioedema/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/fosrenol/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/-/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/honoring-our-japanese-heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-care-gastroenterology/short-bowel--syndrome/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/caring/divercity-next-generation/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/helping-canadian-patients/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/career/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-tarinat/stories/takedan-innovoinnin-ytimessa-olevat-keskeiset-elementit/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/kontaktrs/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/who-we-are/bendradarbiavimas-su-sps/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/videos-covid-19/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/our-stories/heritage/takeda-canadas-history/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/servicos-ao-paciente/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/Declaration-de-confidentialite/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/privacy-policy/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/tietoja-yhtiosta/tietoa-yhtiosta/yritys/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/hematoloji/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/immunoloji/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/who-we-are/corporate-philosophy/pharma-repurposed/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/inflammatory-bowel-disease/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/engagement/mit-immersiven-mitarbeiterinitiativen-um-patienteneinblicke-zu-entdecken/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/-------------/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/politique-daccessibilite/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/who-we-are/politicas-y-procedimientos/competencial-leal/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/Gastro-Enterologie/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/innovation/quality-at-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/Autres/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/nae-prie/briga/koritenje-imerzivnih-inicijativa-za-zaposlenike-za-otkrivanje-stanja-pacijenata/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/accessibility-policy/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/Lo-que-hacemos/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/a-passion-for-sustainability-is-driving-industry-leading-co2-savings-in-austria/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/who-we-are/contact/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-louise-hommerberg-medical-science-liaison-msl-neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/areas-of-focus/plasma-derived-therapies/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/nasze-historie/zaangaowanie/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/lavorare-insieme/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/sitemap/ 2023-08-03 daily 0.7 https://www.takeda.com/en-hk/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/enfermedades-poco-frecuentes/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/what-we-do/joint-working-partnerships/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/what-we-do/domaines-therapeutiques/maladies-rares/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/quienes-somos/acerca-de-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/Sta-mi-radimo/proizvodi2/Pacijenti/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/therapeutische-gebieden/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-tarinat/perinne/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/shonan-health-innovation-park/ 2023-08-03 daily 0.7 https://www.takeda.com/cookie-policy/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/comment-takeda-canada-exerce-ses-activites/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/media/Media_about_us/2022/Interview_S_Salykhova_Kapital/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-verkkosivuston-tietosuojailmoitus/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/kepedulian/safeguarding-plant-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/koullar-ve-yasal-uyarlar/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/talento/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/yhteystiedot/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/research--development/clinical_trial_transparancy/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/terms-of-use/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/2022-new-year-ekiden/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/shared-knowledge-for-a-better-life-for-all/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/for-patienter/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/engagement/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/produkty/lekarsky-informany-servis/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/who-we-are/company_information/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/corporate-responsibility/transparency/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/insult/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/as-nossas-historias/inovacao/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unternehmerische-verantwortung/umwelt-gesundheit--sicherheit/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/innovation/det-nya-aldrandet---hur-ny-teknik-kan-forbattra-dagens-och-framtidens-aldrevard/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/mr/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/wer-wir-sind/unser-unternehmen/takeda-produktion-neuenburg/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/elvis/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/konkurs/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/partners/ourpartners/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/le-cancer-du-poumon/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Contact/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/career/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/aki/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/suppliers/supplier-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/newsroom/2023/nachhaltigkeit-als-gemeinschaftliche-aufgabe/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/information/specialiati_i_organizatsii_zdravoohranenija/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/1/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/who-we-are/about-takeda-canada/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/saglik-calisanlari/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/solidaridad/medicamentos-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/who-we-are/our-people/graduate-and-internship-programmes/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/mantojums/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/corporate-responsibility/transparency/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/utilizar-iniciativas-de-colaboradores-envolventes-para-descobrir-as-perspetivas-dos-doentes/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/inovare/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-careoncology/lymphoma/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-magnus-trovaj-product-manager-neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/pacientes/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/Kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/kepedulian/memanfaatkan-prakarsa-imersif-karyawan-untuk-menyingkap-apa-yang-dirasakan-pasien/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2021/takeda-tar-fram-kunskapsunderlag-om-sallsynta-sjukdomar/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/a-private-sector-approach-to-the-public-health-crisis-of-inequity/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/Erfgoed/de-sleutel-voor-waardig-ouder-worden/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/produktion/oranienburg/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/Novosti-i-saopstenja-za-stampu-kompanije-Takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/a-digital-transformation-to-make-a-global-impact/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Samfunnsansvar/samfunnsansvar/pasientorganisasjoner/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/recherche-et-development/ecosysteme-pour-linnovation-en-sante/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/3/ 2023-08-03 daily 0.7 https://www.takeda.com/investors/overview/offer-for-shire/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/company-information/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/solidaridad/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/politique-sur-les-temoins/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/innovation/med.talk-podcast-new/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/information/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/business-development/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/areas-of-focus/plasma-derived-therapies/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/chi-siamo/modello-organizzativo/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/Lo-que-hacemos/areas-terapeuticas/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/ninlaro/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/produktion/singen/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/what-we-do/takedas-ordbok/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/areas-foco/neurociencias/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/efpia/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/our-medicines/programme-de-reprise-des-medicaments/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/innovatie/een-bijdrage-leveren-binnen-de-zorg-daar-ligt-onze-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/Kontaktai/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/nordic-rare-disease-summit-2023/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-de-privacidad-de-atencion-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/5/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/research--development/corona/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/nos-initiatives/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/earthquake/east-japan/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/quem-somos/eticacompliance/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/terapias-derivadas-de-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/chi-siamo/filosofia-aziendale/codice-di-condotta-globale/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/regulamin-serwisu/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-tarinat/innovaatio/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/lo-que-hacemos/areas-terapeuticas/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/who-we-are/company_information/istoriya/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/prensa/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/neurociencias/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/Takeda_bol_volja/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/produkty/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/what-we-do/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/crm-privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/adhd/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/environment/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/briga/lekovi-za-svet/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/kyoto/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/bs-ba/our-stories/nasljee/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/safety/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/company-history/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/innovation/loser-ehalsa-framtida-generationers-krav-pa-sjukvard/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/takeda-da-kariyer/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/safety/contact/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/pdt/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/environnement/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wie-we-zijn/takeda-nederland/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-tarinat/huolenpito/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/research--development/our_pipeline/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-toiminta/tuotekohtainen-riskienminimointimateriaali/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/humanitarian-access/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/Lo-que-hacemos/areas-terapeuticas/enfermedades-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/etik-ve-uyum-vizyonumuz/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/cuidado/medicamentos-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/lo-que-hacemos/areas-terapeuticas/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/research--development/ecosystem-for-health-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/herencia/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/drones-robots-and-digital-apps-yield-promising-results-for-patients-in-japan/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/une-enune-entreprise-responsable/transparence/associations-de-patients/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/turbota/going-beyond-medicines-to-strengthen-global-health-systems/ 2023-08-03 daily 0.7 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/best-place-to-work/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/corporate-responsibility/covid-19/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/responsabilidad-corporativa/Medio-ambiente-y-Calidad-en-espana/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/advancing-our-manufacturing-processes-with-a-simple-sketch/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/company-information/company-facts/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/impressum/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/-/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/tietoja-yhtiosta/organisaatio/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Vare-historier/Omsorg/Medisin-for-verden/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/access_to_medicines/approach-and-position/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/who-we-are/icc/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/innovazione/terapie-innovative-i-farmaci-biologici/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/avoimet-tyopaikat/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/osteoscreening/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/quem-somos/fale-conosco/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/research/pharmaceutical-sciences/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/tratamientos-derivados-del-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/ochorenia-traviaceho-traktu/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/apoio-as-associacoes-de-pacientes/1-capta--chamamento-ampliado-de-projetos-tematicos-de-associacoes-2023/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/innovatie/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/areas-terapeuticas/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unsere-initiativen/engagement/frauen-in-fuhrung--takedas-initiative-fur-mehr-chancengleichheit-im-eigenen-unternehmen/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/who-we-are/takeda-worldwide/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/hcps/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/was-wir-tun/therapiegebiete/onkologie/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mexico/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/erbe/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/urun-listesi/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/karriere/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/areas-foco/doencas-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-helena-hjertonsson-global-patient-advocacy-lead-gi/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/caring/using-immersive/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/golden/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/who-we-are/icc/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/wer-wir-sind/unser-unternehmen/meilensteine/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/HAE_press-release/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230726_8392/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/cancer-patients/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/areas-of-focus/neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/areas-terapeuticas/enfermedades-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/products/products_kz/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/innovation-is-key-to-sustaining-our-business/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/crohns-disease/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/terapeuticas-derivadas-do-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/farmacovigilance/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/congresos-y-eventos/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/profissionais-de-saude/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/who-we-are/company-information/about-representative-office-of-takeda-pharmaceuticals-at-vietnam/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/iniziative/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/transparence-des-liens/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/aviso-de-privacidad/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/corporate-responsibility/environmental-health-and-safety-policy/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/produtos/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/our-people/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/career/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/magyarorszagon-attekintese/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/our-products/ 2023-08-03 daily 0.7 https://www.takeda.com/et-ee/mida-me-teeme/patsiendiorganisatsioonide-toetamine/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/who-we-are/takeda-i-sverige/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/access-to-medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/crm-privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/how-takeda-canada-does-business/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/rare-diseases/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/recruitment/newgrads/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/pesquisa-e-desenvolvimento/nosso-pipeline/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/terms-of-use/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/termos-e-condicoes-de-uso/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/onkologia/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/grij/a-trece-dincolo-de-medicamente/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/humanitaire-hulp/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/newsroom/news-releases/2023/takeda-opens-digital-health-innovation-challenge-in-partnership-with-plug-and-play-alberta-for-solutions-to-improve-patient-care-in-inflammatory-bowel-disease/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/responsabilite-sociale/redonner-a-la-communaute/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/soins/changer-le-monde---imaginer-lavenir-changer-maintenant/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/what-we-do/domaines-therapeutiques/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/corporate-responsibility/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/corporate-responsibility/csr-thailand/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/all-stories/stories/aspecte-cheie-pentru-inaintarea-in-varst-cu-graie/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/Terms-of-Use/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/areas-of-focus/Rare_deseases/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/executive-leadership/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/inflammatorisk-kroniske-sygdomme/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/vastuullisuus/yhteistyo/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/who-we-are/our-people/careers-at-takeda-uk/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/duyarllk/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/research--development/takeda-clinical-trial-transparency/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/announcements/in-the-news/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/caring/takeda-pharma-spendet-fur-kinderhospiz-netz/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/terms-of-use/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-tarinat/huolenpito/laakkeita-maailmaan/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-emma-silfversward-key-account-manager-hae/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2022/sallsynta-podden--ny-podcastserie-om-sallsynta-sjukdomar-ur-ett-patient--och-anhorigperspektiv/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/our-products-in-new-zealand/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/mention-dinformation-relative-a-la-protection-des-donnees-personnelles/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/congresos-y-eventos/congresos-y-eventos2/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/aider-les-patients-canadiens/onepath/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/corporate-responsibility/global-sosyal-sorumluluk-politikamiz/takeda-turkiye-sorumluluklarmz-ve-odak-noktalarmz/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/corporate-responsibility/product-donations/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/caring/using-immersive/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/terms-of-use/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/announcements/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Vare-historier/Innovasjon/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/motenire/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-toiminta/Laakkeet/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/cukorbetegseg/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/terms-of-use/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/sobre-nos/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/briga/promenimo-svet/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/takedada-hayat-var/takedada-takdir-var/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/our-production/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/corporate-responsibility/taiwan-csr-story/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/access_to_medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/alofisel/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/conformite/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/ko-ms-daram/produkti/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/aviso-legal/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/emesztorendszer/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/contatti/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-noemie-ohman-lead-integrated-care-solutions--patient-support-programs/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/access-to-medicines/clinical_trials/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/mr/Our-Challenge/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/areas-of-focus/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/sistema-nervoso-central-snc/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/nokkeltall/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/turbota/change-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/what-we-do/manufacturing/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/who-we-are/Takeda_in_Ukraine/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/nos-collaborateurs/top-employer/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/areas-of-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/suppliers/supplier-code-of-conduct/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/stories/los-elementos-clave-en-el-centro-de-nuestra-innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/elaprase/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/qualita/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/child/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/presse/nyheter/2022/medisinstudenter-med-sommerjobb-hos-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/maladies-rares/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/investors/financial-highlights/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/quienes-somos/compliance/crm-privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-de-privacidad-profesionales-de-la-salud-takeda-guatemala/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/patients/clinical-trial/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/moving-to-transform-global-child-health-research-with-lshtm/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/who-we-are/company-information/lapprentissage-chez-takeda-neuchatel/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/nasze-historie/dziedzictwo/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/multiple-myeloma/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/karjera/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/Inovasi/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/who-we-are/compliance/crm-privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/lo-que-hacemos/areas-terapeuticas/enfermedades-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/activites-dentreprise-citoyenne/signature-de-la-charte-cancer-et-emploi/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/programmi-di-supporto-al-paziente/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/greetings/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/qui-sommes-nous/informations-sur-la-societe/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/gradimo-poverenje/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/contacts/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/terminos-y-condiciones-de-uso/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/group/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/what-we-do/vara-lakemedel/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/un-azienda-responsabile/takeda-caring-company/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/karriere/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/samarbejdsaftaler/samarbejdsaftaler-shire/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/recherche-et-development/Portefeuille-de-developpement/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/our-medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/corporate-responsibility/COVID_CSR/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/research--development/investigator_initiated_sponsored_research/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/for-jobbsokande/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/Sta-mi-radimo/proizvodi2/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/enfermedades-raras/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2023/vatroslav-mateljiv-ny-medlem-i-lifs-styrelse/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/innovation/digitalisering-av-varden/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/trasparenza/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/Newsroom/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/what-we-do/common-problem/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/lev-med-ibd/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/nos-collaborateurs/flex-office--dans-les-nouveaux-bureaux-de-takeda-france-une-nouvelle-vie-sorganise/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/helping-canadian-patients/our-pipeline-of-new-treatments/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/research-and-development/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/maladie-de-hunter/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/angi1/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/Produktai/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/an-empowered-women-led-workforce-and-the-healthcare-access-they-need/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/iniziative/myhospitalhub-pro/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/improving-health-of-ethnic-minority-women-and-newborns-in-asia/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/malattie-metaboliche-rare/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-bez-recepty/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/cuidado/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/hematologie/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/nuestras-historias/Solidaridad/Medicamentos-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/takedada-hayat-var/takedada-paylam-var/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/who-we-are/company-information/building-trust/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/nuestras-historias/Solidaridad/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/our-strategic-partnership-with-amref-health-africa/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/our-stories/caring/strengthening-the-communities-where-we-live-and-work/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/hcps/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/activites-dentreprise-citoyenne/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/nieuws/Persberichten/2022/takeda-nederland-neemt-stappen-in-duurzaamheid/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/personal_data/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/was-wir-tun/patienten/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/information/Events/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/maatschappelijk-verantwoord-ondernemen/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/karrier/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/healthsupport/subsidy/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/sporg-om-medicin-og-bivirkninger/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/who-we-are/careers---working-at-takeda-belgium/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/company-information/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/healthsupport/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/Sala-de-prensa/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-careoncology/lung-cancer/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/mr/Our-Spirit/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/onkologija/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230628_8390/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/nuestras-historias/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/products/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/paveldima-angioedema-pae/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/kas-ms-esam/privtuma-politika/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/takedainrussia/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/areas-of-focus/enfermedades-poco-frecuentes/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/short-bowel-syndrome/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/investors/financial-results/quarterly-results/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/caring/work/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/areas-of-focus/gastroenterology/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/enhancing-national-laboratories-diagnostic-capabilities-for-covid-19/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/naslede/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2023/L-INESSS-recommande-que-LIVTENCITYMC-maribavir-soit-rembourse-par-le-regime-public-au-Quebec/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/rare-diseases/immunology/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/heritage/keys-to-ageing-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/caring/uso-de-iniciativas-de-inmersion-de-los-empleados-para-descubrir-la-percepcion-del-paciente/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/kas-ms-esam/atbalsts-pacientu-organizcijm/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/transparantieregister/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/mentions-legales/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/retos-metabolines-ligos/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/nasze-historie/all-stories/stories/o-harmonijnym-rozwoju/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/multiple-myeloma/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/takeda-i-norge/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/takedada-hayat-var/takedada-geliim-var/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/bijwerkingen-melden/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/produktion/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/mantelzorg/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/produkty/veejn-pistupna-odborna-informani-sluba-vpois/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/farmakovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Vare-historier/Arv/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/maatschappelijke-code-vereniging-innovatieve-geneesmiddelen/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/social-responsibility/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/who-we-are/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onemocnni-traviciho-traktu/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/un-azienda-responsabile/takeda-per-lambiente/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/apoios-conferidos-a-associacoes-de-doentes/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/kas-ms-esam/sadarbba-ar-veselbas-aprpes-profesioniem/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/areas-foco/terapias-derivadas-do-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/who-we-are/takeda-na-slovensku/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/child/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/contacts/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/rare-diseases/metabolic-diseases/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/chi-siamo/scheda-informativa/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/corporate-responsibility/global-sosyal-sorumluluk-politikamiz/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/nos-histoires/heritage/lhistoire-de-takeda-canada/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedavi-alanlarimiz/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/annual-integrated-report/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/responsabilidad-social-corporativa/responsabilidad-social-corporativa/Tomamos-accion-por-un-mejor-futuro-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/what-we-do/independent-medical-education-grants/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/profesionales-de-la-salud/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/odpowiedzialnosc/kodeks-przejrzystosci/ 2023-08-03 daily 0.7 https://www.takeda.com/ro-ro/povestirile-noastre/stories/elementele-importante-care-stau-la-baza-inovrii-noastre/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/policy/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/une-enune-entreprise-responsable/transparence/medecins-et-organisations-de-sante/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/what-we-do/manufacturing/wien/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/access_to_medicines/clinical_trials/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/servizio-di-medical-information/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/our-stories/innovation/quality-at-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unternehmerische-verantwortung/transparenz/patientenorganisationen/ 2023-08-03 daily 0.7 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/rare-disease-awareness-day/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/corporate-responsibility/quality-control/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/migliorare-la-diagnosi/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/nuestras-historias/all-stories/stories/las-claves-para-envejecer-con-excelencia/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/what-we-do/our-products/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/Miras/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/alcl/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/areas-of-focus/Rare_deseases/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-de-privacidad-profesionales-de-la-salud-takeda-costa-rica/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/areas-of-focus/neurociencias/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wie-we-zijn/takeda-nederland/onze-missie-en-visie/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/what-we-do/takedas-ordbok/real-world-evidence/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/immunologia-rara/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/training-health-workers-to-reach-remote-communities/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/for-vardgivare/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/sobre-nos/cultura-e-valores/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/lutte-contre-la-corruption/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/corporate-responsibility/csr2/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/how-we-work/ 2023-08-03 daily 0.7 https://www.takeda.com/newsroom/newsreleases/2023/takeda-announces-new-assignments-of-directors/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/forskning-og-udvikling/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/contate-nos/ 2023-08-03 daily 0.7 https://www.takeda.com/bg-bg/who-we-are/company-information/building-trust/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/var-historie/var-historie-i-norge/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/Vare-historier/Omsorg/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/nae-prie/inovacije/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/--/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/helping-kids-have-serious-fun/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/nuestras-historias/stories/los-elementos-clave-en-el-centro-de-nuestra-innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/access-to-medicines/approach-and-position/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/what-we-do/domaines-therapeutiques/oncologie/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/Therapiesderiveesduplasma/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/investigacion-y-desarrollo/investigacion-y-desarrollo/ 2023-08-03 daily 0.7 https://www.takeda.com/bs-ba/our-stories/inovacije/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/quienes-somos/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-care-gastroenterology/ibd-uc--cd/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/who-we-are/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/feed/oncologia/setembro-e-o-mes-das-doencas-hemato-oncologicas2/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/neuroscience/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/agb/ 2023-08-03 daily 0.7 https://www.takeda.com/newsroom/newsreleases/2023/takeda-named-global-top-employer/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/what-we-do/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/CSR/takeda-care-program/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/Lo-que-hacemos/areas-terapeuticas/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/who-we-are/company-information/worldwide-offices/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2023/takeda-jednym-z-najlepszych-pracodawcow-na-wiecie/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/who-we-are/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/science/research-and-development/partnerships/cei/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mexico/nuestra-planta-en-mexico/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/science/areas-of-focus/oncology/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/o-que-fazemos/apoio-as-associacoes-de-pacientes/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/partners/ourpartners/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/ledelsen/ledergruppen/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/socialt-ansvar/lif/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/our-stories/stories/novasyon-ruhumuzun-temel-unsurlar/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/sitemap/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/ne-yapiyoruz/tedarikcidavraniskurallari/tedarikci-davran-kurallar/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/vastuullisuus/tuemme/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/farmacovigilancia/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/products/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/seltene-erkrankungen/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/Inovacija/kvalitet-u-kompaniji-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/terveydenhuollon-ammattilaisten-yleinen-tietosuojailmoitus/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/corporate-responsibility/grants-donations-and-sponsorships/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/vart-ansvar/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/vision/ 2023-08-03 daily 0.7 https://www.takeda.com/en-hk/careers/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-per-rydingsvard-business-unit-director-rare-diseases/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/impressum/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/areas-terapeuticas/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/mepact/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/ett-friskare-ostersjon-utan-lakemedel---hur-vi-alla-kan-bidra-till-en-battre-hallbarhet-i-var-narmiljo/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/caring/takeda-spendet-2000-packungen-medikamente-an-das-osterreichische-rote-kreuz/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/who-we-are/politicas-y-procedimientos/entorno-de-trabajo/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/what-we-do/product-portfolio/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/aider-les-patients-canadiens/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/newsroom/news-releases/2022/takeda-canada-innovation-challenge-zoomer-radio-interview/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/was-wir-tun/therapiegebiete/rare-diseases/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/supppliers/pharmaceutical-supply-chain-initiative/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/aider-les-patients-canadiens/vyvanse/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/Newsroom/releases/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/what-we-do/suppliers/ 2023-08-03 daily 0.7 https://www.takeda.com/en-au/what-we-do/research--development/our-pipeline/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/corporate-philosophy2/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/corporate-responsibility/transparency/patient-group-disclosures/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/firazyr/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/our-stories/caring/oncology/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/what-we-do/specialty-careoncology/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/vpriv/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/recognizing-pioneering-researchers-in-gastroenterology/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/who-we-are/positions--guidelines/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/helping-canadian-patients/vyvanse-assistance-program/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/patents/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/colite-ulcereuse/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/as-nossas-historias/cuidar/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/donations-and-grants/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/clinical-trials-and-results/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/presse/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/engagement/die-welt-verandern/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/as-nossas-historias/tradicao/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/who-we-are/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/helsepersonell/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/nase-price/Inovacija/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/innovation/takedas-vision-for-en-hallbar-vard-i-partnerskap/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/rpes/medicina-pasaulei/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/geneesmiddelen/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/kreft/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/Hematologie/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/stories/los-elementos-clave-en-el-centro-de-nuestra-innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/nuestras-areas-terapeuticas-en-mexico/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/pessoas/o-que-oferecemos/ 2023-08-03 daily 0.7 https://www.takeda.com/tr-tr/biz-kimiz/takedada-hayat-var/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/acerca-de-takeda/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-de-privacidad-profesionales-de-la-salud-takeda-panama/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/bewustwording/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/kontakt2/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/what-we-do/manufacturing/orth/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/corporate-responsibility/people/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/prijava-nuspojava2/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/takeda-com-privacy-policy/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/products/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/herencia/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/zorgverleners/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/maatschappelijk-ondernemen/mantelzorg-vriendelijk/hoe-werkt-nederland-video/ 2023-08-03 daily 0.7 https://www.takeda.com/bg-bg/Contact/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/who-we-are/top-employer/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/COVID-19/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/what-we-do/areas-of-focus/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/termini-d-uso/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/nieuws/Persberichten/2022/takeda-ondertekent-oprichtingsakte-van-het-eerste-nederlandse-observatorium/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-medicos/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/who-we-are/company-information/takeda-en-suisse/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/who-we-are/politicas-y-procedimientos/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/kim-jestemy/takeda-w-polsce/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/innovatie/verloop-van-onderzoek/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/rpes/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/takedan-toiminta/sairaudet-ja-oireet/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/cerita-Kami/kepedulian/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/sjaeldne-sygdomme/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unternehmerische-verantwortung/transparenz/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/what-we-do/products/products_kz/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unternehmerische-verantwortung/transparenz/fachkreisangehorige/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/ginecologia/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/productos/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/takedainrussia/plant/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/ 2023-08-03 daily 0.7 https://www.takeda.com/newsroom/newsreleases/2020/takeda-fy2020-h1-results-demonstrate-portfolio-resilience-confirms-full-year-management-guidance--raises-forecasts-for-free-cash-flow-reported-op--reported-eps/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/kariera/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/ansvarsfraskrivelse2/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/gastro-enterologie/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/who-we-are/corporate-philosophy/Takeda_Logo_History/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/what-we-do/research-and-development/investigator-initiated-research/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/our-stories/spad/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/nuestras-historias/stories/Los-elementos-clave-en-el-centro-de-nuestra-innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/who-we-are/building-trust/ 2023-08-03 daily 0.7 https://www.takeda.com/et-ee/mida-me-teeme/koostoo-tervishoiutootajatega/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/who-we-are/compliance/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/farmacovigilanza/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/narita/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/who-we-are/company-information/festschrift-240-jahre-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/media/feed/ 2023-08-03 daily 0.7 https://www.takeda.com/id-id/tanggung-jawab-perusahaan/kegiatan-csr/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/un-azienda-responsabile/l-attenzione-per-il-sociale/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/information/patient_group/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/patients/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/mr/Work-Style/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/access_to_medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/newsroom/news-releases/2021/takeda--240/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/aider-les-patients-canadiens/notre-pepiniere-de-nouveaux-traitements/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/what-we-do/disease--knowledge/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/takeda-a-lechelle-mondiale/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/past-csr-projects/tiromobil/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/medical-fields/reflux/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/herencia/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/var-historie/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/diabetes-cukrovka/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/who-we-are/company-information/takeda-site-de-production-neuchatel/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-hk/what-we-do/our-products/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/modalites-dutilisation/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/pessoas/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/who-we-are/farmakologinis-budrumas/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/ricerca-clinica/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ie/hcps/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/kim-jestemy/takeda-w-polsce/lokalizacje-takeda/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/legitimate-interests-for-transparency-reporting/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvem-vi-er/takeda-i-danmark/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/investors/newsletter/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/recherche-et-development/essais-cliniques/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/who-we-are/politicas-y-procedimientos/canal-etico/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/Message-de-la-DG/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/Neurosciences/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/notrepolitiquerse/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hvem-vi-er/ledelsen/gm-blog/ 2023-08-03 daily 0.7 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onkologie/ 2023-08-03 daily 0.7 https://www.takeda.com/en-be/corporate-responsibility/local-community-engagement/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/our-stories/innovacion/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/innovation/andy_plump/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/Rapport-rse/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/health-care-for-all/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/announcements/shire-announcements/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/partners/ourpartners/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/Our-Stories/innovation/The-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/en-vi/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/Kariera/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/responsabilidade-social-corporativa/responsabilidade-com-a-gestao-da-qualidade/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ec/aviso-de-privacidad/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/corporate-responsibility/corporate-citizenship-activities/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/nos-initiatives/soins/nos-collaborateurs/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/unternehmerische-verantwortung/umwelt-gesundheit--sicherheit/unser-umweltmanagement/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/o-papel-do-cuidador-na-gestao-dos-doentes-com-falencia-intestinal/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/who-we-are/company-information/zusammenarbeit-und-transparenz/ 2023-08-03 daily 0.7 https://www.takeda.com/en-gb/what-we-do/combination-treatments/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/compliance/transparencia/ 2023-08-03 daily 0.7 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/vaksiner/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/mansap/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.7 https://www.takeda.com/en-us/who-we-are/company-information/worldwide-offices/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/sites/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/que-faisons-nous/domaines-therapeutiques--medicaments/Nos-Medicaments-Commercialises/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ch/what-we-do/recherche-et-developpement/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/a-father-experience-with-dengue/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/corporate-responsibility/our-commitment/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/qui-nous-sommes/bienvenue-a-takeda-canada/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/innovation/medicine_for_the_world/ 2023-08-03 daily 0.7 https://www.takeda.com/uk-ua/who-we-are/contacts/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/hvad-vi-laver/forskning-og-udvikling/real-world-evidence/ 2023-08-03 daily 0.7 https://www.takeda.com/en-hk/what-we-do/our-products/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/company/osaka/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/nae-prie/nasljee/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/szovetkezeles/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/ime-se-bavimo/Takeda-terapijska-podrucja/ 2023-08-03 daily 0.7 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/building-trust/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/neurowissenschaften/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/who-we-are/our-partnerships/ 2023-08-03 daily 0.7 https://www.takeda.com/our-impact/our-stories/accelerating-next-generation-cell-therapies/ 2023-08-03 daily 0.7 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/diabetes-cukrovka/ 2023-08-03 daily 0.7 https://www.takeda.com/newsroom/shire-news-releases/2019/Takeda-Completes-Acquisition/ 2023-08-03 daily 0.7 https://www.takeda.com/es-pe/our-stories/caring/medicamentos-para-el-mundo/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-br/responsabilidade-corporativa/relatorio-de-sustentabilidade/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/who-we-are/Takeda_in_KZ/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-kz/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.7 https://www.takeda.com/es-ar/what-we-do/areas-of-focus/terapias-derivadas-del-plasma/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/caring/ 2023-08-03 daily 0.7 https://www.takeda.com/kk-kz/our-stories/caring/using-immersive-employee-initiatives-to-discover-patient-insights/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/gastroenterologija/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/iniziative/TakedaScan/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/social-projects/Ergoroom/ 2023-08-03 daily 0.7 https://www.takeda.com/es-co/lo-que-hacemos/recursos-humanos/ 2023-08-03 daily 0.7 https://www.takeda.com/de-at/our-stories/heritage/ 2023-08-03 daily 0.7 https://www.takeda.com/es-es/que-ofrecemos/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/diabetologia/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/stories/pamatelementi-msu-inovciju-kodolam/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-fr/une-entreprise-responsable/dons/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/who-we-are/parama-pa/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/Takhzyro/ 2023-08-03 daily 0.7 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230712_8391/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/what-we-do/partners/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/unsere-geschichten/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/el-gr/privacy-notice/ 2023-08-03 daily 0.7 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/vendors-and-customers/ 2023-08-03 daily 0.7 https://www.takeda.com/fi-fi/tietoja-yhtiosta/arvot/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/nae-prie/briga/ 2023-08-03 daily 0.7 https://www.takeda.com/th-th/contact-us/ 2023-08-03 daily 0.7 https://www.takeda.com/bs-ba/our-stories/njega/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/karijera/ 2023-08-03 daily 0.7 https://www.takeda.com/he-il/--/products/controloc/ 2023-08-03 daily 0.7 https://www.takeda.com/bs-ba/sta-mi-radimo/Takeda-terapijska-podrucja/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/professionnels-de-la-sante/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/les-maladies-que-nous-traitons/angiodeme-hereditaire/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/who-we-are/takedainrussia/career_russia/ 2023-08-03 daily 0.7 https://www.takeda.com/lt-lt/who-we-are/Skundu-del-produkto-kokybes-pranesimu-apie-nepageidaujamus-reiskinius-ir-prasymu-suteikti-medicinine-informacija-privatumo-pranesimas/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/que-hacemos/areas-terapeuticas/gastroenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/en-ca/what-we-do/conditions-we-treat/gastro-esophageal-reflux-disease-gerd-heartburn/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/disclaimer/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/patients/ethical-provision/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/msu-ststi/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/our-stories/caring/almedalen-2018-vad-hander-med-svensk-halso-och-sjukvard-efter-valet-2018/ 2023-08-03 daily 0.7 https://www.takeda.com/lv-lv/msu-ststi/rpes/zu-nodroinana-lai-stiprintu-globls-veselbas-aprpes-sistmas/ 2023-08-03 daily 0.7 https://www.takeda.com/zh-tw/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/research/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/disclosure/ 2023-08-03 daily 0.7 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/--takeda----------/ 2023-08-03 daily 0.7 https://www.takeda.com/ko-kr/what-we-do/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/Gastrenterologia/ 2023-08-03 daily 0.7 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/fajdalom/ 2023-08-03 daily 0.7 https://www.takeda.com/da-dk/our-stories/innovation/ 2023-08-03 daily 0.7 https://www.takeda.com/ja-jp/who-we-are/research/information/ 2023-08-03 daily 0.7 https://www.takeda.com/it-it/le-nostre-storie/iniziative/vivi-la-vita/ 2023-08-03 daily 0.7 https://www.takeda.com/de-de/was-wir-tun/research--development/hartefallprogramme/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/samenwerking-met-patientenorganisaties/ 2023-08-03 daily 0.7 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/wij-geven-niet-op/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/disclaimer/aviso-candidatos/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/our-medicines/ 2023-08-03 daily 0.7 https://www.takeda.com/sv-se/kontakt/ 2023-08-03 daily 0.7 https://www.takeda.com/hr-hr/sitemap/ 2023-08-03 daily 0.7 https://www.takeda.com/pl-pl/polityka-prywatnoci/ 2023-08-03 daily 0.7 https://www.takeda.com/es-mx/nuestras-historias/all-stories/stories/claves-para-envejecer-con-excelencia/ 2023-08-03 daily 0.7 https://www.takeda.com/pt-pt/quem-somos/sobre-nos/missao-e-visao/ 2023-08-03 daily 0.7 https://www.takeda.com/de-ch/was-wir-tun/therapiegebiete/neurowissenschaften/ 2023-08-03 daily 0.7 https://www.takeda.com/fr-ca/ce-que-nous-faisons/Initiatives-R-et-D-canadiennes/ 2023-08-03 daily 0.7 https://www.takeda.com/ru-ru/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/colite-ulcerosa/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/corporate-responsibility/activities/herhealth/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-updates-its-q1-fy2021-earnings-materials-to-reflect-impact-of-decision-by-the-irish-tax-appeals-commission-relating-to-tax-assessment-on-break-fee-shire-received-from-abbvie/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/seed-global-health-2018/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/what-we-do/research--development/cockpi-t/TA/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/2018-support/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/our-impact/our-stories/harnessing-science-to-push-the-boundaries-of-whats-possible/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2021/informacja-o-realizacji-strategii-podatkowej/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/what-we-do/areas-of-focus/rare-diseases/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2018/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/linfoma-anaplasico-de-celulas-grandes-lacg/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/diagnostika/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/diabetologia/infografica-diabete-mellito-tipo-2/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/keltican/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/initiative-se/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2019/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/newsroom/2023/technische-talente-fur-die-arzneimittelproduktion/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2017/takeda-reports-1st-quarter-fy2017-results/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/controloc/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/-/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2016/takeda-og-omegatri-sammen-om-innovasjon-har-utviklet-omega-3-tablett-uten-sure-oppstot-og-ettersmak/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/2/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/beverley-yamamoto/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unternehmerische-verantwortung/transparenz/fachkreisangehorige/feedbackformular/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/nuestras-historias/cuidado/ir-mas-alla-de-los-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2015/20150917/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/careers/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/---------/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/darbuotojus-traukiani-iniciatyv-panaudojimas-siekiant-suprasti-pacient-patirtis/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/seminar/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/3/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/takedas-gem-bu-aims-to-double-digit-revenue-growth/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company_information/istoriya/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/careers/work_opportunity/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-raras-metabolicas/a-miocardiopatia-hipertrofica-na-doenca-de-fabry---com-a-dr.-catarina-moutinho-ferreira/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/kim-jestemy/informacje-dotyczce-grupy/historia/nasze-symbole-korporacyjne/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/newsroom/statements/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/our-stories/videos-covid-19/emociones-y-medicina/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/patient-group-disclosures/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/directrices-para-la-comunidad-en-redes-sociales/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/8/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2014/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/contacts/almatyoffice_kz/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2015/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-recibe-la-designacion-top-employer-en---latinoamerica-por-segundo-ano-consecutivo/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/Nos-collaborations-avec-les-associations/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/informasi-Perusahaan/Sejarah/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2016/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2017/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Factor_vii/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/disclosure/patient/agreement/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/ginecologia/fibromi-uterini/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Immunate/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/ichstehekopf/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/emesztorendszer/crohn-betegseg/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/siti-web-nazionali/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2012/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2022/takeda-vil-avvikle-produksjon-av-natpar--natpara-til-pasienter-med-hypoparatyreoidisme-innen-utgangen-av-2024/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/corporate-responsibility/programs-in-india/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/bleeding-disorders/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/comunicati-stampa/2023/TAKEDA-PUNTA-FORTE-SULL-ITALIA-ALTRI-22-MILIONI-DI-EURO-SU-RIETI/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2013/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/group/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/faq/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/tachocomb/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/takeda-per-lambiente/green-project/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/stories/kljucniielementi-u-centru-nase-inovacije/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/il-gruppo-takeda/storia/simboli-aziendali/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/bewustwording/lung-cancer-awareness--nog-steeds-veel-onwetendheid-over-longkanker/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/entyvio/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/HyQvia/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/Terapeuticas-Derivadas-do-Plasma/a-rare-condition---as-historias-de-quem-sofre-de-imunodeficiencias-primarias/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/newsroom/news-releases/2023/takeda-has-secured-three-year-contract-in-key-immunoglobulin-category/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/mage--tarmsykdommer/fistler/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mundo/nuestra-historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/istoric/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/gradimo-poverenje/transparentnost/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/quienes-somos/informacion-sobre-la-empresa/historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/takeda-chair/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/-50-25uml/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/datenschutzerklaerung-fur-aerzte/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/korporativna-filozofija/building-trust/interactions-with-patient-organisations/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/bewustwording/oncologie/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2022/laaja-yhteistyo-terveydenhuollon-toimijoiden-kesken-nopeuttaa-diagnoosien-uusien-laakkeiden-ja-innovatiivisten-hoitojen-kehittamista.-suomessa-takeda-oy-kehittaa-edistyksellisia-teknologioita-ja-digitaalisia-palveluita/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2022/takeda-delivers-strong-fy2021-results-continued-growth-momentum-expected-in-fy2022/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2022/maribavir-godkjennes-av-europakommisjonen/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/research--development/clinical_trial_russia/ponatinib-3001/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/kontakt-oss/veibeskrivelse/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/company-facts/standorthistorie/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/carcinoma-mammario/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/kreft/lungekreft/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/gutycare-solution-digitale-pour-les-patients-mici/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/mepact/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/une-enune-entreprise-responsable/transparence/associations-de-patients/rapport-detape-2019/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/wij-geven-niet-op/belofte-jolanda-van-giesen/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/advate/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/kas-ms-esam/uzmuma-informcija/vsture/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/our-stories/stories/health-innovation-challenge/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-raras-metabolicas/rare-podcast-doenca-de-gaucher/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/o-enfermeiro-como-parte-elementar-na-gestao-dos-doentes-com-falencia-intestinal/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/--1200/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/oncology/multiple-myeloma-videos/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/durhane-wong-rieger/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/malattie-metaboliche-rare/sindrome-di-hunter/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/prensa/comunicados-de-prensa/2021/nuevos-resultados-avalan-la-seguridad-y-eficacia--de-la-vacuna-contra-el-dengue-del-laboratorio-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/newsroom/mitteilungen-fur-fachkreise/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/capodanno-darte/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/takeda.com-privacy-policy/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/actovegin-solution-for-injections/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/oncologia/podcast-mieloma-em-multiplas-conversas---nova-temporada/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/Vare-historier/stories/Nokkelelementene-i-hjertet-av-var-innovasjon/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/geneesmiddelen-voor-de-hele-wereld/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2016/20160802/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/ibd/IBD-Patient-Days-and-Virtual-Patient-Days/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2021/covid-19vaccine-suspension-of-use/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/events/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/who-we-are/vallalati-informacio/elzmenyek/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/fale-conosco/Formulario-para-a-solicitacao-de-informacao-medica/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/reflektioner-fran-dagens-medicins-och-takedas-panelsamtal-om-adhd/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kes-me-oleme/ettevotte-teave/ajalugu/meie-korporatiivsed-margid/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/pt-takeda-innovative-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/mage--tarmsykdommer/ulceros-kolitt/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/careers/career-opportunities/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2018/takeda-reports-3rd-quarter-fy2017-results/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2022/kahteen-suuntaan-kulkeva-tieto-on-tulevaisuuden-digitalisoituvan-terveydenhuollon-kulmakivi--uusi-ibd-oirepaivakirjasovellus-pilottikayttoon-taysissa/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/malattie-metaboliche-rare/malattia-di-fabry/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-and-arrowhead-collaborate-to-co-develop-and-co-commercialize-aro-aat-foralpha-1-antitrypsin-associated-liver-disease/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/Cooperation/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/careers/lehre/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company_information/istoriya/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mundo/nuestra-historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2020/takeda-fortsatter-sin-strategi-genom-avyttring-av-tillgangar-som-inte-ingar-i-karnverksamheten-i-europanew-page/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/produits/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/profilaxia/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/ingeborg-rossebo-brude-kommersiell-landssjef-hos-takeda-nycomed/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2021/moderna-and-takedas-response-to-the-incidents-announced/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2016/tolv-medarbeidere-fra-takeda-i-asker-loper-oslo-maraton-for-a-bidra-til-a-gi-kreftpasienter-en-bedre-hverdag/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/sindrome-intestino-corto/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/talento/nuestro-talento/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/career/who-we-are/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/leuplin/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/who-we-are/company-information/historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/alunbrig/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/dexlansoprazole/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/who-we-are/company-information/historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/our-stories/njega/vie-od-lijekova/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/who-we-are/contact/Site-dinformations-sur-les-produits-Takeda-AG-actuellement-en-rupture-de-stock/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-divests-select-non-core-assets-in-europe-to-cheplapharm-for-approximately-$562-million-usd/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/carcinoma-polmonare/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/progress/report/2017_002/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/Gastrenterologia/doenca-de-refluxo-gastro-esofagico-drge/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/progress/report/2017_001/ 2023-08-03 daily 0.6 https://www.takeda.com/science/products/suppliers/tools-and-resources/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/all-stories/stories/kljucne-stvari-za-otmeno-starenje/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/umfragen-se/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/tarihce/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/matyti-daugiau-nei-vien-tik-su-medikamentais-susijusias-problemas/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/mieloma-multiplo/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/novavax-and-takeda-announce-collaboration-for-novavax-covid-19-vaccine-candidate-in-japan/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/patient-group-disclosures/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/contact-us/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unternehmerische-verantwortung/durch-vielfalt-zum-erfolg/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/etude-impaqt/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/unsere-geschichten/all-stories/stories/schlussel-zum-wurdevollen-altern/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-solid-second-quarter-fy2019-results-and-raises-profit-guidance-for-the-full-year/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/careers/career-opportunities/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/wij-geven-niet-op/belofte-yassine-fegrachi/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/who-we-are/company-information/company-facts/-/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/nos-initiatives/all-stories/stories/comment-traverser-les-decennies-avec-dignite/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/colite-ulcerosa/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/linfoma-de-hodgkin-lh/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/careers/life-at-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/patient-services-program/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/ced-tag/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/phase-2-elektra-study-of-soticlestat-tak-935ov935-meets-primary-endpoint-reducing-seizure-frequency-in-children-with-dravet-syndrome-or-lennox-gastaut-syndrome/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/controloc-40mg/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/falencia-intestinal-cronica-a-experiencia-francesa/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/takedavirtuallab/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/sognando-itaca/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/kepedulian/mengubah-dunia/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/heritage/mot-kollegorna-nils-peter-ekholm-medical-advisor-gastroenterologi/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/immunate/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/siga-nos-no-linkedin-em-takedaportugal/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/kim-jestemy/informacje-dotyczce-grupy/historia/19851999r/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/matrifen/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/controloc/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-fy2020-q3-results-demonstrate-growth-acceleration-and-continued-resilience--full-year-management-guidance-for-fy2020-confirmed--forecast-raised-for-free-cash-flow-and-reported-eps/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/access-to-medicine/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-investeert-bijna-300-miljoen-euro/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/newsroom/2023/takeda-lebt-und-liebt-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/who-we-are/company-information/historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2020/mot-oss-pa-sahlgrenska-science-park-annual-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2017/20170126/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Flexbumin/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/aph/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2022/suomalaisena-yhteistyona-kehitetty-full-adhd-mobiilipeli-voitti-reuters-pharma-awards-europe-2022-palkinnon/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/Gastrenterologia/ulcera-peptica/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/what-we-do/research--development/cockpi-t/confirmation/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/ulcera-peptica/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/ALUNBRIG/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/who-we-are/company-information/historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/career/what-we-are-looking-for/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/oncologia/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/briga/promijenimo-svijet/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/new-gm-ebru-yavuz/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/for-vardgivare/material/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Vpriv/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/onkologia/rosszindulatu-limfoma/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/malattia-di-crohn/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/oncology/know-your-blood-tool/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/mieloma-multiplo-mm/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-delivers-strong-h1-fy2021-results-further-growth-momentum-expected-through-fiscal-year-end-driven-by-14-global-brands/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/takeda-nycomed-bytter-navn-til-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/TAKHZYRO/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kes-me-oleme/ettevotte-teave/ajalugu/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/100/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/povijest/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/about/corporate-governance/strategy/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/angioedema-hereditario/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/gynipral-solution-for-injections/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/nasze-historie/zaangaowanie/lek-dla-wiata/ 2023-08-03 daily 0.6 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onemocnni-traviciho-traktu/ulcerozni-kolitida-a-crohnova-nemoc/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/bem-vindo-ao-intestinal-failure-vodcast-introducao-a-sindrome-do-intestino-curto/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/Gastrenterologia/sindrome-do-intestino-curto-com-falencia-intestinal/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/hereditares-angioodem-hae/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/our-stories/duyarllk/guclu-kadnlarn-liderlik-ettii-bir--gucu/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-investit-pres-de-300-millions/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Elaprase/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/nos-projets/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/Bak_biz_turali/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/takeda-care-program/child/story-01/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/zorgverleners/relevante-informatie/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/takeda-care-program/child/story-02/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/takeda-corza-health--tachosil--/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/l-attenzione-per-il-sociale/il-raccordo-tra-arte-e-medicina/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/adcetris/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2018/takeda-reports-first-quarter-fy2018-results/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/gynipral/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/takeda-care-program/child/story-03/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/alla-patienter-som-lever-med-adhd-bor-fa-vard-pa-det-satt-och-den-niva-som-ar-ratt-for-just-dom/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/takeda-care-program/child/story-04/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/for-vardgivare/lankar/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/enabling-innovation-da-tecnologia-a-humanizacao/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/privacy-notice/downloads/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/career/what-we-are-looking-for/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/caring/----2/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/onze-bedrijfssymbolen/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ec/quienes-somos/company-information/Historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/our-stories/duyarllk/dunya-icin-lac/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/informasi-Perusahaan/Sejarah/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kontaktid/privaatsusteatis/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2022/top-employer-2022-reconoce-a-takeda-como-una-de-las-mejores-empresas-para-trabajar-en-espana/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/briga/nadilazenje-lekova/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/jobb/ledige-stillinger/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/novo-site-da-takeda-dedicado-a-sindrome-do-intestino-curto-com-falencia-intestinal/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/farmacovigilanza/comunicazioni/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/-takeda_media/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/briga/zatita-biljne-raznolikosti/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/ochorenia-traviaceho-traktu/ulcerozna-kolitida-a-crohnova-choroba/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/asker-elver-med-to-dagers-grundercamp-800-attendeklassinger-skal-komme-med-forslag-som-gir-bedre-helse/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/tarihce/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/gastroenterologija/uzdegimines-zarnu-ligos-uzl/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/neutralidade-carbonica-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Protrompleks600/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/seltene-metabolische-erkrankungen/hypoparathyreoidismus/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/infografica-colite-ulcerosa-malattia-di-crohn/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-10--dialogar-acerca-da-doenca-de-crohn-fistulizante/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/what-we-do/areas-of-focus/neuroscience/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Takhzyro/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/winaars-2023/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/Takhzyro/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/farmacovigilancia/farmacovigilancia-eventos-adversos/ 2023-08-03 daily 0.6 https://www.takeda.com/science/products/manufacturing/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/takedainrussia/plant/fotos/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/doenca-inflamatoria-do-intestino/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/il-gruppo-takeda/storia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Gattestive/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-strong-first-quarter-fy2019-results-and-raises-guidance-for-the-full-year/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/newsroom/2023/pharmazeutische-versorgung-resilient-und-nachhaltig/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Resolor/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2021/febrisan-wycofanie/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/angioedema-hereditario/o-angioedema-hereditario-e-uma-doenca-genetica-rara-2/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/3-edicao-da-newsletter-takeda-o-valor-do-plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/f50/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/career/obog/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/kontakt-oss/spor-oss/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/our-people/fun-at-work/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/stories/advancing-our-manufacturing-processes-with-a-simple-sketch/ 2023-08-03 daily 0.6 https://www.takeda.com/th-th/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/malattie-metaboliche-rare/malattia-di-gaucher/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Vpriv/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/istorija/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/who-we-are/company-information/history/-2/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/our-stories/duyarllk/dunyay-deitirelim/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/amici-contro-le-mici/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unternehmerische-verantwortung/umwelt-gesundheit--sicherheit/umwelterklarungen-und-zertifikate/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/sallsynta-sjukdomar/behov-av-samordning-i-varldsklass/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/immunologia-rara/angioedema-ereditario/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/angioedema-hereditario/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/morbus-hunter/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/our-impact/our-stories/integrating-data-sciences-into-clinical-development/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/research-and-development/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/vaccine/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/patologie-gastroesofagee-acido-correlate/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/sostegno-al-linfoma/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/sindrome-intestino-corto/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Contact/onze-contactgegevens/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/corporate-responsibility/disclosure-of-csr-committee-composition/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/---------------/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/il-gruppo-takeda/storia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/historia/simbolos-coorporativos/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/stories/kertiniai-mus-inovacij-elementai/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/magen-darm-erkrankungen/reflux-bis-magengeschwur/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/countries/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/controloc-solution-for-injections/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/our-impact/our-stories/pursuing-life-transforming-science/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-continua-consolidando-su-estrategia-de-crecimiento-mediante-la-venta-de-activos--no-estrategicos-en-america-latina/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-inaugure-une-nouvelle-unite-de-production-biotechnologique-de-pointe-sur-son-site-de-lessines-en-belgique/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/Newsroom/takeda-na-midia/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/Pressrelease/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/building-trust/transparency/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/gynipral-concentrate-for-solution-for-infusion/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/contacts/adr-plant/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/actovegin-tablets/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/informasi-Perusahaan/Sejarah/simbol-perusahaan-kami/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/onkologie/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/all-stories/stories/kunci-menua-dengan-anggun/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/urologie/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/hemofilia/takeda-e-aph-lancam-guia-de-hemofilia-para-pacientes-e-profissionais-de-saude/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2020/parp/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/winaars-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/nos-initiatives/soins/aller-au-dela-des-medicaments-pour-renforcer-les-systemes-de-sante-mondiaux/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/kreft/lymfekreft/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/news-releases/2021/Press-release/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/turbota/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/all-stories/stories/melampaui-lingkup-obat-obatan/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-logro-la-neutralidad-de-su-huella-de-carbono-en-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/all-stories/stories/ir-alem-dos-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/25/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/transparencia/transferencias-de-valor/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/oncologia/mieloma-multiplo-na-primeira-pessoa--conheca-o-testemunho/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/news-releases/2021/-takeda-pharmaceuticals--240-----/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ec/quienes-somos/company-information/Historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/transparencia/colaboracion-con-asociaciones-de-pacientes/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/our-stories/videos-covid-19/emociones-y-pacientes/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/contacts/call-centertakeda/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/Vare-historier/all-stories/stories/Hvordan-man-eldes-med-stil/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/preserver-la-diversite-pour-le-generations-futures/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/20-deltagere-fra-takeda-nycomed-til-start-for-team-aktiv-i-oslo-maraton/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/unternehmerische-verantwortung/transparenz/patientenorganisationen/tatigkeitsbericht-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/effort/ 2023-08-03 daily 0.6 https://www.takeda.com/investors/overview/offer-for-shire/shire-offer-bond-offering-documents/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/johan-prevot/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/seminar/onlinediscussion-6/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/career/vacancies/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Elaprase/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/dexilant/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/nieuws/Persberichten/2023/catharina-ziekenhuis-winnaar-van-de-patient-centricity-award-2023/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/aktiv-mot-kreft-apner-pusterom-for--kreftsyke-ved-sentralsykehuset-i-vestfold/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/20/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/a-family-affair-how-takeda-cares/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/contacts/press_contact_kz/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/istorija/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/hemofilia-a-profilaxia-permite-atividade-fisica-regular/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/th-th/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/angioedema-hereditario/dia-mundial-de-consciencializacao-do-angioedema-hereditario/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/career/joining-us/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/mezavantru/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/interne-medizin/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/patologie-gastroesofagee-acido-correlate/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/progressdata/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/reach-italia---missione-bambini/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/advancing-leadership-of-women-and-girls/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/caring/advancing-health-equity-built-on-trust/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-resalta-el-impacto-emocional-de-vivir-con-la-enfermedad-inflamatoria-intestinal/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/adcetris/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/linfoma-nao-hodgkin-lnh/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/kepedulian/tenaga-kerja-dengan-fokus-pada-pemberdayaan-perempuan/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/nos-histoires/all-stories/stories/cles-pour-vieillir-avec-grace/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/briga/lijek-za-svijet/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/innovation/les-moteurs-de-notre-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/vpriv/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/istorija/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/askers-beste-unge-entreprenorer-premieres-etter-at-800-elever-har-jobbet-i-prosjekt-for-et-friskere-asker/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/nos-histoires/soins/une-medecine-pour-le-monde/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/den-internasjonale-osteoporosedagen-20.-oktober---slik-kan-nordmenn-fa-i-seg-nok-kalsium/ 2023-08-03 daily 0.6 https://www.takeda.com/th-th/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/contacts/reaction/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/AntithrombinIII/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/nuestras-historias/all-stories/stories/ir-mas-alla-de-los-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/etude-mici-et-travail/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/fredrik-arneberg-helseokonom-hos-takeda-nycomed/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-raras-metabolicas/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/2019-shire-support/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2016/160519/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/Terapeuticas-Derivadas-do-Plasma/world-pi-week-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2021/top-employer-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/what-we-do/areas-of-focus/plasma-derived-therapies/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-7--problemas-masculinos/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/trabalhadores-capacitados-chefiados-por-mulheres/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/careers/to_shine/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/newsroom/news-releases/2022/u.s.-food-and-drug-administration-accepts-takedas-supplemental-biologics-license-application/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/privacy-notice/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/research/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/riopan-tablets/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/executive-leadership/uyum-sozumuz/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/ppsb/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/take-care-diabete-sotto-controllo/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/career/our-culture/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/quienes-somos/informacion-sobre-la-empresa/historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/bulding-trust/transparency/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/advate/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/ginecologia/endometriosi/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/prensa/comunicados-de-prensa/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2020/covid-19-och-tillgang-till-takedas-lakemedel---2020-04-06/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/a-third-less/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/swapna-k/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/adcertis/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/ir-alem-dos-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/sal-de-lectur/companynews/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/newsroom/pressemitteilungen/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/ne-yapiyoruz/hasta-derneklerine-yapilan-bagislar/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/Firazyr/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/who-we-are/company-information/history/-/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/takeda-overlater-nokkelen-til-curida/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/wer-wir-sind/kontakt/Uebersicht-der-aktuell-nicht-verfuegbaren-Produkte-von-Takeda-Pharma-AG/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2023/takeda-lance-le-defi-de-linnovation-en-sante-numerique-en-partenariat-avec-plug-and-play-alberta/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/blutgerinnungsstorungen/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-raras-metabolicas/impacto-covid-19-doencas-raras/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/procedimento-descentralizado/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/corporate-responsibility/takeda-india-csr-policy/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2020/crisis-sanitaria-dificulta-el-diagnostico-temprano-y-el-tratamiento-de-pacientes-con-cancer-en-la-sangre/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/hubungi-kami/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/controloc-20mg/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/istorijat/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/building-trust/sponzorstva/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/oncology/Patient-Days-for-Oncology/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/building-trust/transparency/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/hypoparathyreoidismus/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/african-medical-and-research-foundation/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/-----------------/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/darbo-jga-moterims-suteikus-galimybes/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/sallsynta-sjukdomar/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2020/takeda-continues-divestiture-strategy-with-sale-of-select-otc-and-non-core-assets-in-europe-to-orifarm-for-up-to-approximately-670m-usd/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/istoric/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/lancering-van-het-eerste-patientenregister-voor-kortedarmsyndroom-in-belgie/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante-capitulo2/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-destaca-la-necesidad-de-un-abordaje-integral-para-mejorar-la-calidad-de-vida-de-pacientes-con-mieloma-multiple/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2022/takedan-qdenga-on-hyvaksytty-kaytettavaksi-denguetaudin-ennaltaehkaisyyn-euroopan-unionissa/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/building-trust/transparency/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/wij-geven-niet-op/belofte-carin-louis/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/enabling-innovation-da-tecnologia-a-humanizacao-reveja/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/sapori-e-salute-in-tavola/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/funding/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/informacao-da-empresa/nossa-historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/kepedulian/melampaui-lingkup-obat-obatan/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/research-development/clinical-trials/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mundo/nuestra-historia/nuestra-simbologia-corporativa/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-presente-un-dessin-anime-educatif-sur-la-maladie-de-crohn-pour-expliquer-de-maniere-vivante-aux-enfants--le-diagnostic-les-symptomes-les-traitements-de-la-maladie/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/what-we-do/areas-of-focus/gastroenterology/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/quienes-somos/informacion-sobre-la-empresa/historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/stories/kljuni-elementi-u-srcu-naih-inovacija/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/reflektioner-fran-takedas-seminarium-om-sallsynta-halsotillstand/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ec/quienes-somos/company-information/Historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/sallsynta-sjukdomar/gemensam-nationell-strategi-som-vag-framat/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2018/takeda-reports-second-quarter-fy2018-results/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/links-uteis/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/gradimo-poverenje/transparentnost/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/informacao-da-empresa/nossa-historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/hae-is-a-family-affair-how-we-can-drive-progress-for-families-together/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/what-we-do/our-medicines/shire-products/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/caring/an-empowered-women-led-workforce-and-the-healthcare-access-they-need/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/official-instagram/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/quiz-ibd/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-delivers-solid-first-quarter-fy2021-results-positioning-company-to-accelerate-topline-growth-and-continued-pipeline-progress/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-receives-decision-by-the-irish-tax-appeals-commission-relating-to-tax-assessment-on-break-fee-shire-received-from-abbvie/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/briga/ouvanje-razliitog-bilja/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/contactmedical/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/sei-un-tipo-2/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/hjernehelse/sovn/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/people/ 2023-08-03 daily 0.6 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onkologie/osteosarkom/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/hikari/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/istorijat/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/careers/contact-us/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/septembre-rouge--un-mois-pour-parler-des-cancers-du-sang/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/hemofilia/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/what-we-do/terapias-teruletek/emesztorendszer/a-refluxtol/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/datenschutzerklarung-fur-bewerber/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/financial-results/quarterly-results-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/emergenza-sorrisi/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/disclosure/medical-shire/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/onkologia/osteosarkom/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/takeda-privacy-notice/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/gastropatia-da-fans/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/lo-que-hacemos/investigacion-y-desarrollo/investigacion-y-desarrollo/rd-en-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ec/quienes-somos/company-information/Historia/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/kepedulian/takeda-di-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/newsroom/news-releases/2023/takeda-presents-full-data-set-from-phase-3-ADVANCE-CIDP-1-clinical-trial-investigating-HYQVIA%C2%AE-as-a-maintenance-therapy-for-chronic-inflammatory-demyelinating-polyneuropathy-CIDP-at-PNS-annual-meeting/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2016/takeda-receives-$38-million-grant-from-the-bill--melinda-gates-foundation-to-support-polio-eradication-in-developing-countries/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/rare-diseases/patient-days-rare-diseases/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/ZEJULA/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/our-impact/our-stories/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/HumanAlbumin/ 2023-08-03 daily 0.6 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onemocnni-traviciho-traktu/refluxni-choroba-jicnu-vedova-choroba-aludku-a-dvanactniku/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/ibd-unmasked/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/careers/hr_contact-us_fr/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/flexbumin/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/who-we-are/vallalati-informacio/elzmenyek/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-raras-metabolicas/ser-raro/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/quiz-linfoma/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/Our-Stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/f100/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/news-releases/2022/best_employer/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/news-releases/2021/HAE_press-release/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/prensa/comunicados-de-prensa/2021/dengue-una-enfermedad-que-afecta-mas-a-las-poblaciones-vulnerables/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/ninlaro/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/careers/personnel-system/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/la-unidad-de-negocios-mercados-emergentes-y-en-crecimiento-de-takeda-apunta-a-generar-un-incremento-de-dos-digitos-en-sus-ingresos-durante-la-proxima-decada/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-presents-new-data-highlighting-scientific-advancements-in-lung-cancer--at-esmo-virtual-congress/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/25th-anniversary-of-the-metropolitan-zoos-endowment-program/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/erkrankungen-des-verdauungssystems/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/lessons-on-the-wall/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/lo-que-hacemos/investigacion-y-desarrollo/investigacion-y-desarrollo/proceso-de-descubrimiento-de-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/povijest/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/farmaci-mondo/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company_information/istoriya/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/-/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/careers/life-at-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/gastropatia-da-fans/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/takeda_tachosil_corza/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/contacts/shema/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/takeda-to-present-23-company-sponsored-abstracts/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/actoveg/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/o-acesso-a-medicamentos-em-situacoes-especiais/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2022/takeda-obtiene-la-distincion-top-diversity-company/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/1/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/save-the-children-2016/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-03/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/2/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/all-stories/stories/tenaga-kerja-dengan-fokus-pada-pemberdayaan-perempuan/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/hemofilia/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/pakeiskite-pasaul/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/3/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/4/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/Terapeuticas-Derivadas-do-Plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/trg/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/cancro-do-pulmao-de-nao-pequenas-celulas-cpnpc/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/malattie-metaboliche-rare/ipoparatiroidismo/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/building-trust/interactions-with-patient-organisations/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/tietoja-yhtiosta/tietoa-yhtiosta/historia/takedan-yrityssymbolit/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/takeda-ticad-konferencijoje/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/briga/ii-dalje-od-lijekova/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/Ukrainian_patients_with_hereditary_angioedema_get_access_to_modern_treatment_for_the_first_time/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/stipsi-cronica/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2022/ke-zatwierdzia-maribawir-w-leczeniu-zakaenia-cmv-po-przeszczepie/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/our-stories/videos-covid-19/emociones-y-tu/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-raras-metabolicas/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/2021-takeda-support/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/find-my-trial/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/iaea-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/angioedema-hereditario/tratamento-inovador-para-o-angioedema-hereditario-disponivel-em-portugal/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/---------/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/stories/honoring-our-japanese-heritage-and-advancing-efforts-to-fight-covid-19/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/mudar-o-mundo/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Albumin/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/comunicati-stampa/2021/al-via-la-campagna-raro-chi-trova-una-caccia-al-tesoro-digitale-sulle-tracce-delle-malattie-rare-da-accumulo-lisosomiale--per-accrescere-linformazione-e-favorire-la-diagnosi/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/sallsynta-sjukdomar/nar-diagnosen-drojer/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/xeforapid/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Rixubis/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/patients/essential-thrombocythemia/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/associazione-andrea-tudisco-onlus-il-valore-dellaccoglienza/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/500100020002/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/access-to-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/stories/evi-found-a-team-who-makes-her-feel-heard/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/takeda-e-apdi-lancam-experiencia-interativa-sobre-doenca-de-crohn-o-que-deve-a-clara-fazer/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/transparencia/Shire-Transparencia/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2020/takeda-ja-arrowhead-yhteistyohon-alfa1-antitrypsiinin-puutokseen-liittyvan-maksasairauden-aro-aat-hoidon-kehittamisessa-ja-kaupallistamisessa/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kes-me-oleme/ettevotte-teave/ajalugu/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/ninlaro/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/filosofia-aziendale/canale-per-le-segnalazioni/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/Takeda-Applied-for-Selection-of-Prime-Market-Filed-Corporate-Governance-Report-with-Tokyo-Stock-Exchange-TSE-in-Line-with-Revised-Corporate-Governance-Code-and-Published-Corporate-Governance-related-Documents-on-its-website/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/farmacovigilancia/formato-para-notificacion-de-eventos-adversos/enlaces-de-interes/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/screening_lung_cancer/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/who-we-are/company-information/historia/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/doenca-de-gaucher/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-destaca-el-diagnostico-temprano-de-mieloma-multiple-como-esencial-para-evitar-complicaciones/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/lansoprazole/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/materiali-istituzionali/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/what-we-do/research--development/cockpi-t/platform/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/gastroenterologie/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/il-gruppo-takeda/storia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-raras-metabolicas/doenca-de-gaucher-uma-condicao-subdiagnosticada---com-a-dr.-maria-de-fatima-ferreira/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/transparencia/aviso-legal-transparencia/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/registo-de-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/procedimento-centralizado/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/solkrem-beskytter-mot-bade-sol-og-d-vitamin/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-13/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2022/takeda-delivers-strong-third-quarter-fy2021-results-and-raises-full-year-forecast-reflecting-strong-momentum/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/newsroom/takeda-deutschland-auf-social-media/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/caring/creating-value-and-sustainable-access-to-medicine-in-todays-health-care-system/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/mansap/our-culture/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/first-patient-enrolled-in-nih-phase-3-trial-to-evaluate-potential-covid-19-hyperimmune-medicine/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/prensa/comunicados-de-prensa/2021/mieloma-multiple-conozca-por-que-es-un-cancer-silencioso-pero-letal-en-los-pacientes-que-luchan-contra-ella/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2022/czterowalentna-szczepionka-przeciw-gorczce-denga-dopuszczona-do-uytku-w-unii-europejskiej/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/onkologia/maligne-lymfomy/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/corporate-responsibility/activities/digital-birth-program/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-raras-metabolicas/afetacao-renal-na-doenca-de-fabry---com-a-dr.-ana-cabrita/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/anvandarvillkor/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/nos-histoires/stories/les-elements-cles-au-cur-de-notre-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/An-innovative-drug-for-the-treatment-of-patients-with-short-bowel-syndrome-has-been-registered-in-Russia/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2017/20170403/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/caring/building-trust-between-the-pharma-industry-and-black-and-brown-communities/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2016/innovasjonscamp-for-150-skoleelever-bleiker-elever-skal-gi-takeda-rad-om-kommunikasjon-med-unge/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2017/takeda-reports-first-half-fy2017-results/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/dexilant/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/farmacovigilancia/formato-para-notificacion-de-eventos-adversos/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/ulcera-peptica/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/stories/innovation-is-key-to-sustaining-our-business/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-9--organizacoes-de-apoio/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/replagal/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-raras-metabolicas/projeto-guimaraes/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/entyvio/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/takeda-pharmaceuticals---240----/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/myhospitalhub/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/sindrome-de-hunter/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/oncologia/setembro-e-o-mes-das-doencas-hemato-oncologicas/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Ceprotin/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2016/20161212/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/spreke-medarbeidere-hos-takeda-nycomed-i-elverum-gar-stafettbirken/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/comunicati-stampa/2023/alessandra-fionda-nominata-medical-and-regulatory-head-di-takeda-italia/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/ricerca-e-sviluppo/aree-terapeutiche2/gastroenterologia/malattia-di-crohn/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/kas-ms-esam/uzmuma-informcija/vsture/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-expands-covid-19-vaccine-supply-in-japan-through--partnership-with-moderna-and-government-of-japan/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/oncologia/linfomas-cutaneos-de-celulas-t-lcct/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/mage--tarmsykdommer/crohns-sykdom/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/our-stories/heritage/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/what-we-do/areas-of-focus/vaccines/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/tagliamo-corto/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/briga/kompanija-takeda-u-ticad-u/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-presenteert-een-educatief-tekenfilmpje-over-de-ziekte-van-crohn-diagnose-symptomen-behandelingen-op-een-levendige-manier-aan-kinderen-uitgelegd/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/5007501000/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/corporate-responsibility/activities/global-relay-for-life/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Feiba/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2018/asker-fotball/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/top-employer-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-opens-new-rd-cell-therapy-manufacturing-facility-to--support-expansion-of-next-generation-clinical-programs/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/our-stories/videos-covid-19/emociones-y-familia/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/procedimento-nacional/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mexico/innovation-capability-center-mexico/explora-la-sede/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2022/komunikat-do-fachowych-pracownikow-ochrony-zdrowia/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/ceraxon-solution-for-oral-injection/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Firazyr/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/rixubis/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-6---viagens/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/moviprep/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/advate/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/caring/new-u.s.-health-equity-collaboration-aims-to-improve-health-outcomes-in-new-orleans/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/adynovate/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/ceraxon-solution-for-oral-use/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/building-trust/interaction-with-patients-organizations/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2021/takeda-finaliserar-avyttring-av-utvalda-produkter-till-orifarm/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/world-patient-safety-day-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mundo/nuestra-historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2020/inbjudan-hur-kan-lou-anvandas-for-att-skapa-sammanhallna-vardkedjor-for-personer-med-adhd/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/contacts/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/contact/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/oncologia/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/riopan-solution-for-oral-use/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kes-me-oleme/ettevotte-teave/ajalugu/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2022/nextpharma-og-takeda-kunngjor-fremtiden-for-farmasoytisk-produksjonsanlegg-i-asker/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/covig-19-plasma-alliance-builds-strong-momentum-through-expanded-membership-and-clinical-trial-collaboration/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/quienes-somos/informacion-sobre-la-empresa/historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/stories/kernelementen-in-het-hart-van-onze-innovatie/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/kreft/benmargskreft/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/about/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/povijest/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/doltard/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/informasi-Perusahaan/Sejarah/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/who-we-are/company-information/historia/nuestros-simbolos-corporativos/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/careers/our-culture/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/turbota/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/who-we-are/company-information/historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/kas-ms-esam/uzmuma-informcija/vsture/msu-uzmuma-simboli/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/disclosure/patient/funding/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kontaktid/tervishoiutootajate-privaatsusteatis/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/quem-somos/informacao-da-empresa/historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/et-ee/kes-me-oleme/ettevotte-teave/ajalugu/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/istorijat/nai-korporativni-simboli/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/------/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/novembre-perle--cancer-du-poumon-parlons-en/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/istorija/nasi-korporativni-simboli/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/osteosarcoma-un-tumore-raro/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/newsroom/newsreleases/2018/20180726-7990/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs-in-action/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/sal-de-lectur/social-media/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/doencas-raras/doencas-de-fabry/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/entyvio/ 2023-08-03 daily 0.6 https://www.takeda.com/about/leadership/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/our-stories/all-stories/stories/tajna-gracioznog-starenja/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/acerca-de-takeda/takeda-en-mundo/nuestra-historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/diabetologia/il-diabete-mellito-di-tipo-2/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-bez-recepty/controloc-control/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/-2/ 2023-08-03 daily 0.6 https://www.takeda.com/about/our-company/corporate-philosophy/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/building-a-coalition-to-drive-early-diagnosis-and-hope/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/ameliorer-la-sante-des-femmes-dans-les-pays-en-developpement-et-emergents/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/therapeutic--areas/Gastrenterologia/doenca-inflamatoria-do-intestino/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/oncology/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/nieuws/Persberichten/2023/takhzyro-lanadelumab-vanaf-1-juni-vergoed/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/2020-takeda-support/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/caring/safeguarding-plant-diversity-for-future-generations/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/all-stories/stories/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/il-linfoma-di-hodgkin-e-il-linfoma-non-hodgkin-salcl/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/adhs/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/kim-jestemy/informacje-dotyczce-grupy/historia/19451984r/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/careers/benefits/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/joicfp-2017/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/eurordis-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/medicine-for-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2021/milta-adhd-tuntuu-uusi-peli-kuvaa-adhd-kokemusmaailmaa/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Replagal/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/a-new-drug-for-the-treatment-of-hemophilia/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/strandmoen-naringsutvikling-kjoper-takeda-nycomeds-fabrikk-i-elverum/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/ibd/toilet-pass-campaign/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/hjernehelse/autisme/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Ceprotin/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/turbota/safeguarding-plant-diversity-for-future-generations/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-8--problemas-femininos/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/takeda-junta-se-a-comunidade-global-para-celebrar-o-dia-internacional-contra-o-dengue/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/oncologia/o-impacto-do-mieloma-multiplo-em-portugal/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/innovation/l-immunite-innee-une-nouvelle-approche-dans-le-traitement-des-cancers/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/keltican/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2022/nu-lanseras-takeda-academy/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2021/investigation-of-suspended-lots-of-covid-19-vaccine-in-japan/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/science/research-and-development/partnerships/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/informacao-da-empresa/nossa-historia/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/patient-first/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/news-releases/2021/Pressrelease/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-to-divest-tachosil-to-corza-health-for-350-million/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-demonstrates-business-momentum-accelerated-integration-synergies-and-raises-fy2019-guidance-including-positive-reported-operating-profit/ 2023-08-03 daily 0.6 https://www.takeda.com/th-th/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Cuvitru/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/mansap/what-we-are-looking-for/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/sallsynta-sjukdomar/storre-kliv-for-att-halla-jamna-steg-med-framsteg-inom-forskningen/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/science/pipeline/ 2023-08-03 daily 0.6 https://www.takeda.com/en-gb/corporate-responsibility/transparency-disclosures/patient-organisations/2020-shire-support/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/a-realidade-dos-cuidados-de-saude-em-falencia-intestinal-cronica-em-portugal/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/corporate-responsibility/commitment-to-community/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/takeda-selger-sin-lungeportefolje-til-astra-zeneca/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/who-we-are/company-information/historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/profilo-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/finalistas-life-enablers-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/a-nova-newsletter-da-takeda-dedicada-as-terapeuticas-derivadas-do-plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-to-divest-its-japan-consumer-health-care-business-unit-to-blackstone-for-jpy-242.0-billion/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2018/16052018/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/Exkivity/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/who-we-are/company-information/company-facts/-2/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/contact/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/hereditares-angioodem/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/investigator-initiated-research/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2018/neo-fer/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/msu-ststi/all-stories/stories/pamatieteikumi-k-sasniegt-briedumu-ar-cieu/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/media/Media_about_us/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/moviprep/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/privacy-notice/telechargements/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2023/sztuczna-inteligencja-kt%C3%B3ra-przyspiesza-diagnoz%C4%99-chor%C3%B3b-rzadkich-z-rekomendacj%C4%85-WHIH/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/22/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Jouw-gezondheid/informatie-over-geneesmiddelen/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/message-from-milano/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/who-we-are/vallalati-informacio/elzmenyek/vallalati-szimbolumaink/ 2023-08-03 daily 0.6 https://www.takeda.com/cs-cz/what-we-do/oblasti-lecby/onkologie/maligni-lymfomy/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/mage--tarmsykdommer/kort-tarm-syndrom/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/21/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Onze-verhalen/zorg/wij-geven-niet-op/belofte-tessa-de-winter/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/informacao-da-empresa/nossa-historia/os-nossos-simbolos-empresariais/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/disclosure/patient-shire/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/research--development/clinical_trial_russia/vedolizumab-3035/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/ProthromplexTotalNF/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/newsroom/newsreleases/2018/20180514_7966/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2018/takeda-reports-fy2017-full-year-results-and-issues-fy2018-guidance/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/newsroom/media-resources/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/Ko-smo-mi/company-information/istorija/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/jmo-meg-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/newsroom/news-releases/2023/tacademy/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/immunology/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/winaars-patient-centricity-award-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/povijest/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/feiba/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/patients/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/ceo-message/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/winaars-patient-centricity-award-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/salvaguardar-a-diversidade-de-plantas/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/who-we-are/company-information/historia/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/new-perspective/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/our-stories/caring/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/immundefekte/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/ADCETRIS/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/contact-us/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/innovation/notre-expertise-scientifique/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/corporate-responsibility/activities/global-csr-program/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/ADYNOVATE/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-hk/who-we-are/company-information/history/our-corporate-symbols/ 2023-08-03 daily 0.6 https://www.takeda.com/terms-and-conditions/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/takedainrussia/plant/plant_tour/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/members-of-the-covid-rd-alliance-and-quantum-leap-healthcare-collaborative-enroll-first-patients-in-i-spy-covid-trial/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/who-we-are/company-information/worldwide-offices/em-bu/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/newsroom/unternehmensmaterialien/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/non-aspettando-godot/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/tarihce/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/caritasil-diritto-difare-la-spesa/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/innovation-and-elimination-of-ntds/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/progress/report/2018_003/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Firazyr/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/CSR/takeda-care-program/healthsupport/interview/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/our-stories/innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/ibd/in-their-shoes/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/access-to-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company_information/istoriya/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/media/comunicati-stampa/2021/raro-chi-trova-si-conclude-la-campagna--dedicata-alle-malattie-da-accumulo-lisosomiale/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/cerita-Kami/all-stories/stories/safeguarding-plant-diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2021/takedas-response-to-the-new-incident-announced/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/summary-report/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/newsroom/2023/dampf-ohne-gas---forschungsprojekt-ahead/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/science/clinical-trials/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/stock-information/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Kiovig_ru/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/what-we-do/research-development/1/4/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/what-we-do/research-development/1/3/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/takeda-continues-to-advance-the-diagnosis-and-treatment-of-bleeding-disorders-at-ash-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/de-plus-en-plus-de-talents-etrangers-viennent-travailler-et-etudier-en-belgique--devenir-un-peu-la-silicon-valley/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/istorijat/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-digital-transformation-with-accenture-and-aws/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/what-we-do/research-development/1/2/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/caring/answering-the-call-how-takeda-cares/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Advate/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/career/how-to-join-us/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/who-we-are/company-information/historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/caring/ibd/patient-blogs/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/quem-somos/informacao-da-empresa/nossa-historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/morbus-gaucher/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/briga/osnaena-radna-snaga-voena-enama/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/our-production/api-manufacturing/ 2023-08-03 daily 0.6 https://www.takeda.com/en-vi/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/vencedores-life-enablers-2020/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/agire-onlus-e-croce-rossa-italiana-sempre-nelle-emergenze/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/science/areas-of-focus/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/astrid-rostvig-mage-fra-bekkestua-skal-tilbringe-et-ar-i-brasil/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/warfarin/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/newsroom/press-releases/takeda-first-pharmaceutical-company-in-belgium--to-obtain-the-lean--green-label/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/le-3000eme-patient-inclus-dans-realysa-une-etude-en-vie-reelle-sur-les-lymphomes/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/our-stories/caring/change-the-world-imagine/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/ce-que-nous-faisons/our-medicines/liste-des-produits-shire/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/eurodin/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/disclosure/post-marketing/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/all-stories/stories/ouvanje-razliitog-bilja/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/takeda-nycomed-og-asker-fotball-arrangerer-idrettsdag-for-lokalt-naringsliv/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-delivers-resilient-fy2020-results-with-strong-margins--robust-cashflow-underlying-revenue-growth-expected-to-accelerate-in-fy2021/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ec/quienes-somos/company-information/Historia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/all-stories/stories/salvaguardar-a-diversidade-de-plantas/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/our-products/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/corporate-responsibility/global-csr-program/takeda-initiative/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/as-nossas-historias/cuidar/medicamentos-para-o-mundo/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/what-we-do/our-production/ksm-manufacturing/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/briga/osnaene-ene-osnauju-kolektiv/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2016/med-nycopro-laktase-kan-de-som-ikke-taler-laktose--spise-vanlig-mat/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/our-stories/all-stories/stories/yi-yalanmann-srlar/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-3--nutricao/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/livtencity/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2016/20160718/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/es-ar/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2022/takeda-reconocida-como-una-de-las-100-mejores-empresas-para-trabajar-en-espana-en-2022/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/careers/ausbildung-bei-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/2-edicao-da-newsletter-takeda-o-valor-do-plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/unsere-geschichten/engagement/uber-arzneimittel-hinausgehen/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/caring/----/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/sal-de-lectur/archive2017/2017/strategic-agreements-for-takedas-portfolio-in-oncology-and-gastroenterology/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/urologia/iperplasia-prostatica-benigna/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/patient-centricity-award/winaars-patient-centricity-award-2017/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/istoric/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/sr-rs/nase-price/all-stories/stories/osnaene-ene-osnauju-kolektiv/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/pharmaceutical-companies-leaders-in-therapy-based-on-blood-plasma-derivatives-have-teamed-up-to-accelerate-the-development-of-a-therapeutic-drug-against-covid-19/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/bewustwording/blood-cancer-awareness-bewustwording-bloedkanker-blijft-van-belang/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--guia-completo/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/patient-labhome/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/otcproducts_kz/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/research--development/clinical_trial_russia/Brigatinib-3001/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/Agrylin/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Kiovig/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-destaca-la-importancia-del-diagnostico-oportuno-en-pacientes-con-linfoma-de-hodgkin/ 2023-08-03 daily 0.6 https://www.takeda.com/id-id/siapakah-Kami/informasi-Perusahaan/Sejarah/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/hcps-privacy-notice/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/sec-filings-and-security-reports/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/neuroscience/adhd/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/comunita-di-santegidio/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/Raplagal/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/who-we-are/about-zydus-takeda/our-people/a-walk-through-at-vashi-site/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/takedan-tarinat/all-stories/stories/arvokkaan-vanhenemisen-salaisuus/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/careers/initiativbewerbung/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/step/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/what-we-do/pagalbos-pacientams-programa-ppp/gastroenterologija/trump-arn-sindromas-ts/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/takeda-al-fianco-delle-istituzioni/lean-management/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/contacts/drugsafety_kz/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/terms-of-use/social-media-guidelines/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/hcps/geschuetzt/onkologie/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/an-empowered-women-led-workforce/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/medikamentai-pasauliui/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/kim-jestemy/informacje-dotyczce-grupy/historia/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/our-stories/duyarllk/laclarn-otesine-gecmek/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/takeda-digital-health-innovation-challenge/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/--/medical-fields/3/------/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/hvad-vi-laver/produkter/neuroscience/sovnloshed/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/oncologia/cancro-alla-prostata/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/newsroom/news/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/la-nostra-esperienza/aree-terapeutiche/gastroenterologia/quiz-ibd/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/all-stories/stories/----2/ 2023-08-03 daily 0.6 https://www.takeda.com/en-us/our-stories/stories/helping-kids-have-serious-fun-despite-the-pandemic/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/o-que-fazemos/pesquisa-e-desenvolvimento/o-valor-de-um-farmaco/o-resumo-das-caracteristicas-do-medicamento-rcm-e-o-folheto-informativo-para-o-doente/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-kz/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/helsepersonell/Spor-oss/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/conheca-a-doenca-inflamatoria-intestinal-dii/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/terapeuticas-derivadas-do-plasma/4-edicao-da-newsletter-takeda-o-valor-do-plasma/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wie-we-zijn/Informatie-over-ons-bedrijf/Geschiedenis/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/bjorn-lie-ny-sjef-for-takeda-nycomed-i-norge/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/istoric/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/kim-jestemy/informacje-dotyczce-grupy/historia/2000obecnie/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/dei/recognition/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/instanyl/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/works/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2021/takeda-announces-approval-of-modernas-covid-19-vaccine-in-japan/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/a-abordagem-do-cirurgiao-na-falencia-intestinal-cronica/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/summary-report2/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/careers/takeda-ism/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Antithrombin/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/Jouw-gezondheid/ziektebeelden/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ch/what-we-do/therapiegebiete/Neurosciences/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/cuidar/takeda-no-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2023/takeda-amplia-plazo-de-presentacion-de-solicitudes-a-la-tercera-edicion-de-ayudas-a-proyectos-innovadores-en-TDAH/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/angioedema-hereditario/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/l-attenzione-per-il-sociale/la-mostra-di-national-geographic-sulla-condizione-umana-e-sulla-vita-sul-nostro-pianeta/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/que-faisons-nous/nos-engagements/notice-dinformation-transferts-de-valeurs-aux-professionnels-de-sante/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/entyvio/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/innovation/nos-engagements-institutionnels/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/povijest/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/wat-we-doen/patient-centraal/zeldzame-ziektendag/rachel-callander/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/ro-ro/who-we-are/company-information/istoric/simbolurile-noastre-corporative/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2016/160824/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/contacts/sklad/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2017/170523/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/patients/morbus-fabry/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/contactsideeffects/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/alofisel/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-ca/careers/our-culture/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/all-stories/stories/graktus-kelias--brand/ 2023-08-03 daily 0.6 https://www.takeda.com/en-be/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/our-stories/caring/change-the-world/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/investors/public-notice/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/corporate-responsibility/global-sosyal-sorumluluk-politikamiz/takeda-turkiye-sorumluluklarmz-ve-odak-noktalarmz/cevre-farkndalk-ve-sosyal-dayanma/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/prensa/comunicados-de-prensa/2022/takeda-es-nombrada-en-el--ranking-top-employer-latam-por-3er-ano-consecutivo-y-fue--reconocida-como-top-employer-en-colombia-por-5to-ano/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/corporate/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/stories/the-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/nae-prie/all-stories/stories/kljuevi-za-dostojanstveno-starenje/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/kas-ms-esam/uzmuma-informcija/vsture/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-transformation-solid-fy2019-results-confidence-in-fy2020-growth-momentum/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/unsere-initiativen/engagement/tag-der-seltenen-erkrankungen/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/our-stories/caring/takeda-at-ticad/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-5---exercicio/ 2023-08-03 daily 0.6 https://www.takeda.com/nl-nl/nieuws/Persberichten/2023/eerste-vaccin-tegen-dengue-in-nederland/ 2023-08-03 daily 0.6 https://www.takeda.com/da-dk/hvad-vi-laver/sporg-om-medicin-og-bivirkninger/lagemidler-med-uddannelsesmateriale/instanyl/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/who-we-are/vallalati-informacio/elzmenyek/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/Ceprotin/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/ 2023-08-03 daily 0.6 https://www.takeda.com/en-ca/newsroom/news-releases/2023/takeda-announces-results-from-phase-4-vedolizumab-study-in-patients-with-chronic-pouchitis-published-in-new-england-journal-of-medicine/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/nuestras-historias/all-stories/stories/ir-mas-alla-de-los-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/efpia/2022/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/18/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/pressrum/pressmeddelanden-nyheter/2021/takeda-flyttar-till-nytt-kontor-pa-kungsholmen/ 2023-08-03 daily 0.6 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/ethics/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/stories/os-elementos-chave-no-coracao-da-nossa-inovacao/ 2023-08-03 daily 0.6 https://www.takeda.com/en-au/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/talento/crece-con-nosotros/ 2023-08-03 daily 0.6 https://www.takeda.com/es-mx/talento/que-buscamos/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/as-nossas-historias/all-stories/stories/trabalhadores-capacitados-chefiados-por-mulheres/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/elaprase/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/what-we-do/products/divested-products/13/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2015/ny-reseptfri-nodprevensjon/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/careers/arbeiten-bei-takeda/ 2023-08-03 daily 0.6 https://www.takeda.com/jp/about/corporate-governance/charters-and-reports/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/oncologia/podcast-mieloma-multiplas-conversas/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2016/nytt-nettsted-om-lindring-av-kreftsmerter/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Obizur/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/stories/The-key-elements-at-the-heart-of-our-innovation/ 2023-08-03 daily 0.6 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/in-their-shoes/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/all-stories/stories/principi-chiave-per-durare-nel-tempo/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/lv-lv/kas-ms-esam/uzmuma-informcija/vsture/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/ 2023-08-03 daily 0.6 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/inbjudan-tidig-upptackt-och-vard-av-adhd--vad-ar-problemet/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/as-nossas-historias/cuidar/salvaguardar-a-diversidade-de-plantas/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/hva-vi-gjor/Behandlingsomrader/hjernehelse/adhd/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/contacts/talentacquisition_kz/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/nuestras-historias/solidaridad/ir-mas-alla-de-los-medicamentos/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/who-we-are/company-information/bulding-trust/interactions-with-patient-organizations/ 2023-08-03 daily 0.6 https://www.takeda.com/el-gr/our-stories/caring/going-beyond-medicines/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/quienes-somos/informacion-sobre-la-empresa/historia/nuestros-simbolos-corporativos/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/fondazione-u.veronesi-oncologia-e-non-solo/ 2023-08-03 daily 0.6 https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-third-quarter-fy2018-results/ 2023-08-03 daily 0.6 https://www.takeda.com/he-il/our-stories/innovation/Takeda-helps-to-harness-virtual-reality/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/who-we-are/informacije-o-kompaniji/istorijat/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/gli-ideogrammi-della-salute/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/dexilant/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/who-we-are/research/jmo-frg/ 2023-08-03 daily 0.6 https://www.takeda.com/de-at/careers/diversity/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-br/as-nossas-historias/all-stories/stories/como-envelhecer-com-graciosidade/ 2023-08-03 daily 0.6 https://www.takeda.com/kk-kz/press-ortalyk/janalyktar/2021/Top_Employers_2021/ 2023-08-03 daily 0.6 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2020/takedan-alunbrig-brigatinibi-on-hyvaksytty-eussa-alk-positiivisen-ei-pienisoluisen-keuhkosyovan-hoitoon-ensilinjassa/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/pressekontakt/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/hemofilia-o-testemunho-de-nuno-lopes-presidente-da-aph/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/newsroom/news-releases/2020/takeda_top_employer_2021/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/media/feed/doencas-gastrointestinais/guia-para-viver-melhor-com-a-doenca-de-crohn-fistulizante--capitulo-4---familia-e-amigos/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Immunine/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/newsroom/news-releases/2021/------------/ 2023-08-03 daily 0.6 https://www.takeda.com/de-ch/produkte/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/what-we-do/products/prescription-drugs/ceraxon-tablets/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/iniziative/maratona-di-roma/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2022/bezpieczny-lek-bezpieczny-pacjent/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/what-we-do/therapeutic--areas/ochorenia-traviaceho-traktu/refluxna-choroba-paeraka-gastroezofagealny-reflux-a-aludony-a-dvanastnikovy-vred/ 2023-08-03 daily 0.6 https://www.takeda.com/pt-pt/takeda-talks/doencas-gastrointestinais/intestinal-failure-vodcast/o-papel-do-farmaceutico-na-gestao-dos-doentes-com-falencia-intestinal/ 2023-08-03 daily 0.6 https://www.takeda.com/es-pe/prensa/comunicados-de-prensa/2021/takeda-enfatiza-la-importancia-del-diagnostico-en-los-primeros-meses-de-vida-para-pacientes-con-sindrome-de-hunter/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Feiba/ 2023-08-03 daily 0.6 https://www.takeda.com/es-co/prensa/comunicados-de-prensa/2021/takeda-continua-consolidando-su-estrategia-de-crecimiento-mediante-la-venta-de-activos--no-estrategicos-en-america-latina/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/jobb/en-attraktiv-arbeidsplass/ 2023-08-03 daily 0.6 https://www.takeda.com/sk-sk/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/hu-hu/who-we-are/vallalati-informacio/elzmenyek/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/what-we-do/our-products/REVESTIVE/ 2023-08-03 daily 0.6 https://www.takeda.com/pl-pl/co-robimy/produkty/leki-na-recepte/Adynovi/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/careers/apply/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/tarihce/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/lt-lt/ms-istorijos/aistra-padti-kitiems/augal-vairovs-isaugojimas-ateities-kartoms/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/le-nostre-storie/stories/elementi-chiave-innovazione/ 2023-08-03 daily 0.6 https://www.takeda.com/de-de/was-wir-tun/therapeutic--areas/magen-darm-erkrankungen/colitis-ulcerosa-und-morbus-crohn/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2018/01042018/ 2023-08-03 daily 0.6 https://www.takeda.com/it-it/chi-siamo/il-gruppo-takeda/storia/1985-1999/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/our-stories/turbota/an-empowered-women-led-workforce-and-the-healthcare-access-they-need/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/recruitment/takeda-ma/ 2023-08-03 daily 0.6 https://www.takeda.com/bs-ba/our-stories/stories/kljuni-elementi-i-sutina-naih-inovacija/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/our-stories/all-stories/stories/keys-to-aging-gracefully/ 2023-08-03 daily 0.6 https://www.takeda.com/hr-hr/tko-smo-mi/o-nama/gradimo-poverenje/interakcije-sa-udruenjima-pacijenata/ 2023-08-03 daily 0.6 https://www.takeda.com/ru-ru/what-we-do/products/ceraxon/ 2023-08-03 daily 0.6 https://www.takeda.com/zh-tw/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.6 https://www.takeda.com/ja-jp/announcements/2021/statement-regarding-moderna-covid-19-vaccine-recall-investigation-report--october-2021/ 2023-08-03 daily 0.6 https://www.takeda.com/th-th/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.6 https://www.takeda.com/bg-bg/newsroom/news-releases/2022/-------1----------------/ 2023-08-03 daily 0.6 https://www.takeda.com/en-in/our-stories/caring/ 2023-08-03 daily 0.6 https://www.takeda.com/uk-ua/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.6 https://www.takeda.com/tr-tr/biz-kimiz/irket-bilgileri/tarihce/kurumsal-sembollerimiz/ 2023-08-03 daily 0.6 https://www.takeda.com/ko-kr/newsroom/news-releases/2018/17042018/ 2023-08-03 daily 0.6 https://www.takeda.com/nn-no/presse/nyheter/2014/takeda-nycomed-prisen-2014/ 2023-08-03 daily 0.6 https://www.takeda.com/about/leadership/marcello-agosti/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/erica/ 2023-08-03 daily 0.5 https://www.takeda.com/it-it/media/comunicati-stampa/2023/in-sicilia-la-telemedicina-al-servizio-dei-pazienti/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-begins-regulatory-submissions-for-dengue-vaccine-candidate-in-eu--and-dengue-endemic-countries/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/u.s.-food-and-drug-administration-accepts-new-drug-application-for-review-grants-priority-review-for-takedas-tak-721-budesonide-oral-suspension-for-the-treatment-of--eosinophilic-esophagitis/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210511-8260/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-01/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/alunbrig/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2023/abordaje-integral-y-visibilizacion-fundamentales-para-los-pacientes-con-enfermedades-raras/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210730-8283/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-presents-positive-results-for-mobocertinib-in-patients-with-egfr-exon20-insertion-mnsclc-who-received-prior-platinum-based-chemotherapy/ 2023-08-03 daily 0.5 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/contact/ 2023-08-03 daily 0.5 https://www.takeda.com/en-ca/newsroom/news-releases/2022/health-canada-approves-takedas-livtencity-maribavir-the-first-and-only-treatment-for-adults-with-post-transplant-cytomegalovirus-cmv-infection/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-07/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-06/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-09/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-08/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-03/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/faq/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-02/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2019/20190201-8045/ 2023-08-03 daily 0.5 https://www.takeda.com/el-gr/EmailPrivacyPolicy/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-05/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/positions/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201029-8209/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/d-i/empowerment-project/employee-04/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/cambian-mujeres-cientificas-curso-de-la-historia/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230117_8364/ 2023-08-03 daily 0.5 https://www.takeda.com/science/products/suppliers/sustainable-procurement/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-achieved-carbon-neutrality-in-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/efpia/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/effort/age-free/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-01/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/research-and-development/partnerships/iir/ 2023-08-03 daily 0.5 https://www.takeda.com/about/our-company/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/universal-health-coverage-and-the-power-of-people-side-event/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2017/20170728_7804/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/health-care-for-all/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-05/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/enhancing-national-laboratories-diagnostic-capabilities-for-covid-19/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-04/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/takeda-announces-approval-of-nuvaxovid-covid-19-vaccine-for-primary-and-booster-immunization-in-japan/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-03/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2023/takeda-annonce-les-resultats-de-l-etude-de-phase-iv-sur-vedolizumab-chez-des-patients-atteints-de-pochite-chronique-dans-le-new-england-journal-of-medicine/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-02/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200713-8188/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/entyvio/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/people-06/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/our-company/history/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/faq/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/acce%CC%80s-pre%CC%81coce-post-AMM-Livtencity/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/training-health-workers-to-reach-remote-communities/ 2023-08-03 daily 0.5 https://www.takeda.com/it-it/media/comunicati-stampa/2023/takeda-e-uniamo-lanciano-rare2aware-tutti-i-giorni-al-fianco-dei-pazienti-rari/ 2023-08-03 daily 0.5 https://www.takeda.com/it-it/media/comunicati-stampa/2023/assistenza-oncologica-domiciliare-avviato-in-puglia-il-primo-progetto-pilota-di-sanita-digitale/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/serious-fun-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/transparencia/transferencias-de-valor/transferencias-de-valor-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/purpose-led-sustainability-governance/materiality/ 2023-08-03 daily 0.5 https://www.takeda.com/ko-kr/careers/personnel-system/college-intern/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-to-acquire-maverick-therapeutics-to-advance-t-cell-engager-therapies-for-solid-tumors-and-expand-novel-immuno-oncology-portfolio/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-tachosil-to-corza-health/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2021/takeda-continua-consolidando-su-estrategia-de-crecimiento-mediante-la-venta-de-activos--no-estrategicos-en-america-latina/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/european-commission-approves-takedas-alunbrig-brigatinib-as-a-first-line-treatment-for-alk-nsclc/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-named-global-top-employer-for-fourth-consecutive-year/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/equasym/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/enfermedad-inflamatoria-intestinal-el-padecimiento-silencioso-que-afecta-a-las-personas-en-su-etapa-mas-productiva/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220511_8327/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200513-8154/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-ch/une-enune-entreprise-responsable/transparence/associations-de-patients/rapport-detape-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/takedas-takhzyro-lanadelumab-approved-in-japan-for-prophylaxis-against-acute-attacks-of-hereditary-angioedema-hae/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/new-phase-3-data-show-tak-620-maribavir-an-investigational-drug-for-the-treatment-of-transplant-recipients-with-refractoryresistant-cytomegalovirus-cmv-infections-meets-primary-endpoint/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/research-and-development/partnerships/t-cira/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ziektebeelden/immuundeficienties/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2019/20191031-8102/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/three-stories-of-crisis-action-and-putting-patients-first/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/transparencia/transferencias-de-valor/transferencias-de-valor-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/building-a-mother-focused-health-system-in-india/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/drones-robots-and-digital-apps-yield-promising-results-for-patients-in-japan/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/products/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/multiples-myelom/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/milano-furuta/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/relevante-informatie/ibd/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2019/20190731-8090/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/water/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/moving-to-transform-global-child-health-research-with-lshtm/ 2023-08-03 daily 0.5 https://www.takeda.com/ko-kr/careers/personnel-system/compensation/ 2023-08-03 daily 0.5 https://www.takeda.com/en-in/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/a-private-sector-approach-to-the-public-health-crisis-of-inequity/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/yoshihiro-nakagawa/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/worlds-leading-life-science-companies-now-enrolling-community-a-global-platform-trial-for-hospitalized-patients-with-covid-19/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-completes-sale-of-select-otc-and-non-core-assets-to-celltrion-in-asia-pacific/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/julie-kim/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/angioedema-hereditario-condicion-poco-frecuente-cronica-e-impredecible/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/investigator-initiated-research/agreement/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/glossary/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/takeda-entre-las-cinco-mejores-empresas-en-el---ranking-top-employer-en-mexico/ 2023-08-03 daily 0.5 https://www.takeda.com/zh-tw/newsroom/news/2022/20220126/ 2023-08-03 daily 0.5 https://www.takeda.com/pl-pl/aktualnosci/informacje-prasowe/2023/informacja-o-realizowanej-strategii-podatkowej-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/la-enfermedad-de-los-reyes-que-padecen-6-mil-mexicanos--la-hemofilia/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2023/takeda-a-obtenu-un-contrat-de-trois-ans-pour-une-importante-categorie-d-immunoglobuline/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/plan-international-2017/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/andrew-plump/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/prostatakarzinom/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/newsroom/news-releases/2022/fda-approves-prophylactic-treatment-with-vonvendi/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/what-we-do/areas-of-focus/vaccines/our-focus-areas/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/Entyvio/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/supporting-recovery-in-tohoku/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/research-and-development/partnerships/public-private-partnerships/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/helping-kids-have-serious-fun/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/media/news-releases/2021/corza-health/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/ramona-sequeira/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/erkrankungen-des-verdauungssystems/saurebedingte-erkrankungen/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210802-8284/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/potential-impact-of-takedas-dengue-vaccine-candidate-reinforced-by--long-term-safety-and-efficacy-results/ 2023-08-03 daily 0.5 https://www.takeda.com/en-in/who-we-are/company-information/history/1781-1944/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/responsibly-translate-science/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/211101-8303/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/alofisel-darvadstrocel-shows-clinical-remission-rate--at-six-months-in-the-real-world-inspire-study-interim-analysis-consistent-with-the-pivotal-clinical-admire-cd-study/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-presents-real-world-evidence-at-ash-2020-demonstrating-its-long-standing-commitment-to-personalizing-treatments-for-rare-bleeding-disorders/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/our-progress-towards-environmental-sustainability/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/newsroom/news-releases/2023/takeda-announces-fy22-us-csr-program-partners-and-first-us-csr-report/ 2023-08-03 daily 0.5 https://www.takeda.com/en-in/who-we-are/company-information/history/2000-/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-furthers-innovation-focused-strategy-in-china-with-sale-of-select-non-core-assets-to-hasten-for-$322-million-usd/ 2023-08-03 daily 0.5 https://www.takeda.com/pt-pt/media/feed/doencas-raras-metabolicas/apl-lanca-brochura-sobre-a-doenca-mucopolissacaridose-mps/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/media/news-releases/2021/summary-report/ 2023-08-03 daily 0.5 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2021/alunbrig-valmisteen-rajoitettu-peruskorvattavuus-voimaan-1.2.2021 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/plan-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/zh-tw/newsroom/news/2022/20220613/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-ca/nos-histoires/innovation/defidelinnovationsante/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210204-8237/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/teresa-bitetti/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/honoring-our-japanese-heritage/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/effort/lgbtq-and-sogi/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/empowering-ethnic-minorities-to-improve-health-in-myanmar/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220203-8314/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/evi/ 2023-08-03 daily 0.5 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/Reflektioner-fran-Takedas-och-Dagens-Medicins-panelsamtal-om-sallsynta-diagnoser/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/products/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/clinical-trials/pre-approval-access/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ziektebeelden/ibd/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/statement-regarding-moderna-covid-19-vaccine-recall-investigation-report--october-2021/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/contacts/talentacquisition/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/shared-knowledge-for-a-better-life-for-all/ 2023-08-03 daily 0.5 https://www.takeda.com/en-in/who-we-are/company-information/history/1945-1984/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/investigation-of-suspended-lots-of-covid-19-vaccine-in-japan/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unfpa-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200204-8128/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/nos-initiatives/nos-etudes/Portail-d%E2%80%99information-relatif-aux-%C3%A9tudes-de-Takeda-France/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unfpa-2021/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unfpa-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/works/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/last-mile-health/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-governance/governance-structure/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/an-empowered-women-led-workforce-and-the-healthcare-access-they-need/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-livtencity-maribavir-approved-by-us-fda/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/HyQvia/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/relevante-informatie/oncologie/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/effort/nationality-equality/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/internship01/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t_scr/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/newsroom/festschrift-240-jahre-takeda/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/find/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/instanyl/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-announces-approval-of-takhzyro-lanadelumab-subcutaneous-injection-in-china-for-the-treatment-of-hereditary-angioedema/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/aki/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/what-we-do/areas-of-focus/rare-diseases/personalized-care-for-patients-living-with-rare-diseases/ 2023-08-03 daily 0.5 https://www.takeda.com/science/clinical-trials/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/final-results-from-the-phase-3-help-study-open-label-extension-support-takhzyro-lanadelumab-flyo-injection-as-a-long-term-preventive-treatment-option-in-patients-with-hereditary-angioedema/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/alknsclc/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/research-and-development/partnerships/tdv/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-and-idt-support-manufacturing-of-johnson--johnsons-covid-19-vaccine/ 2023-08-03 daily 0.5 https://www.takeda.com/ro-ro/sal-de-lectur/social-media/termeni-de-utilizare/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/covig-19-plasma-alliance-announces-topline-results-from-nih-sponsored-clinical-trial-of-investigational-covid-19-hyperimmune-globulin-medicine/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/recognizing-pioneering-researchers-in-gastroenterology/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/effort/gender-equality/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/what-we-do/areas-of-focus/vaccines/infographics/ 2023-08-03 daily 0.5 https://www.takeda.com/de-ch/was-wir-tun/therapiegebiete/rare-diseases/hereditares-angioodem-hae/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/herhealth/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/supporting-global-covid-19-response/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/takedas-takhzyro-open-label-phase-3-study-met-its-objectives-in-children-ages-2-to-12-years-of-age-with-hereditary-angioedema/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/a-digital-transformation-to-make-a-global-impact/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-select-otc-and-non-core-assets-to-hypera-pharma/ 2023-08-03 daily 0.5 https://www.takeda.com/de-de/newsroom/mitteilungen-fur-fachkreise/geschuetzt/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-provides-updates-on-phase-12-clinical-trials-of--novavax-and-modernas-covid-19-vaccine-candidates-in-japan/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-ch/what-we-do/domaines-therapeutiques/maladies-rares/angio-odeme-hereditaire/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/llega-hernan-porcile-a-dirigir-takeda-en-mexico/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/gastro-enterologie/un-acteur-historique-en-gi/ 2023-08-03 daily 0.5 https://www.takeda.com/zh-tw/newsroom/news/2022/20221125/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-selects-four-new-partners-for-annual-global-corporate-social-responsibility-csr-program-to-help-strengthen-health-systems-in-low--and-middle-income-countries/ 2023-08-03 daily 0.5 https://www.takeda.com/fi-fi/Uutiset/Uutiset/2021/valittujen-itsehoitovalmisteiden-ja-reseptilaakkeiden-siirtyminen-orifarmille-1.4.2021 2023-08-03 daily 0.5 https://www.takeda.com/fr-ca/salle-de-presse/communiques-de-presse/2023/takeda-presente-des-resultats-concrets-sur-l-efficacite-clinique-et-l-innocuite-concernant-le-vedolizumab-entyvio-et-l-ustekinumab-comme-traitement-biologique-de-premiere-intention-contre-la-maladie-de-crohn/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/decarbonizing/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/city-cancer-challenge/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-achieves-industry-leading-positions-in-2021-access-to-medicine-index/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/contacts/press_contacts/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/koki-sato/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/a-passion-for-sustainability-is-driving-industry-leading-co2-savings-in-austria/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2019/20190514-8063/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-announces-u.s.-fda-grants-priority-review-for-new-drug-application-for-mobocertinib-tak-788-as-a-treatment-for-egfr-exon20-insertion-metastatic-non-small-cell-lung-cancer/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/japanese-clinical-study-tak-919/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/supporting-the-people-who-fight-cancer/ 2023-08-03 daily 0.5 https://www.takeda.com/ko-kr/careers/personnel-system/career-development/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-select-non-core-assets-to-cheplapharm/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/access-to-health-fund-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/thomas-wozniewski/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/a-father-experience-with-dengue/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/newsroom/news-releases/2023/takeda-receives-fda-approval-to-expand-the-use-of-hyqvia/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/contacts/drugsafety/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/who-we-are/company-information/history/about-nycomed/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/realizing-sustainability-in-health-systems/ 2023-08-03 daily 0.5 https://www.takeda.com/el-gr/who-we-are/company-information/bulding-trust/interactions-with-patient-organizations/2019/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-manufacturing-facilities-in-japan-and-ireland-recognized-with-category-awards-for-2021-facilities-of-the-year/ 2023-08-03 daily 0.5 https://www.takeda.com/kk-kz/press-ortalyk/Bak_biz_turali/Egemen/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/elvis/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/instanyl/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210806-8286/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/hasta-25-de-pacientes-con-cancer-de-pulmon-son-no-fumadores/ 2023-08-03 daily 0.5 https://www.takeda.com/en-in/who-we-are/company-information/history/1985-1999/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/que-son-las-enfermedades-raras-y-por-que-no-son-tan-raras-como-parecen/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/elvanse/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/media/news-releases/2021/screening_lung_cancer/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ondersteunend-materiaal/alofisel/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/what-we-do/areas-of-focus/rare-diseases/shared-decision-making-aid/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/hikari/interview/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/nos-initiatives/Engagements_patients/mois-du-myelome-multiple/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/innovation-is-key-to-sustaining-our-business/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ziektebeelden/hae/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/activities/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2023/Expertos-en-gastroenterologia-proponen-recomendaciones-para-la-mejora-de-la-atencion-a-los-pacientes-a-partir-de-las-lecciones-aprendidas-de-la-COVID-19/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/who-we-are/company-information/history/changes-to-the-corporate-logo/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/moderna-and-takedas-response-to-the-incidents-announced/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2023/deporte-y-actividad-fisica-mas-alla-de-la-hemofilia/ 2023-08-03 daily 0.5 https://www.takeda.com/ru-kz/media/news-releases/2021/Top_Employer_2021/ 2023-08-03 daily 0.5 https://www.takeda.com/zh-tw/newsroom/news/2023/0223/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2023/los-estudios-de-takeda-implicaron-a-715-pacientes-en-investigacion-clinica-y-a-3428-pacientes-en-investigacion-aplicada/ 2023-08-03 daily 0.5 https://www.takeda.com/about/board-of-directors/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/waste/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2018/20180201_7911/ 2023-08-03 daily 0.5 https://www.takeda.com/da-dk/our-stories/caring/Medarbejderne-er-i-fokus/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/our-strategic-partnership-with-amref-health-africa/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/intuniv/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/erkrankungen-des-verdauungssystems/chronisch-entzundliche-darmerkrankungen/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/maladies-rares/journee-des-maladies-rares/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/Jouw-gezondheid/ziektebeelden/oncologie/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/Cooperation/atm/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/faq-01/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/faq-02/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/alofisel/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/mwana-lugogo/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/shonan-health-innovation-park/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/expanding-neglected-patient-access/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2016/CSR-Programs-Focusing-on-Maternal-and-Child-Health/ 2023-08-03 daily 0.5 https://www.takeda.com/en-au/what-we-do/research--development/cockpi-t/application-form/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/christophe-weber/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/takeda-initiative-2/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/research-and-development/partnerships/cei/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/disclosure/public-funds/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/takeda-initiative-1/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2022/takeda-recibe-opinion-positiva-de-la-ema-y-recomienda-la-aprobacion-de-su-vacuna-candidata-contra-el-dengue-en-la-ue-y-en-los-paises-donde-el-dengue-es-endemico/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/talent-management/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/ 2023-08-03 daily 0.5 https://www.takeda.com/it-it/un-azienda-responsabile/un-azienda-solidale/susan-g.komen 2023-08-03 daily 0.5 https://www.takeda.com/kk-kz/press-ortalyk/Bak_biz_turali/the-day-of-the-fight-against-cancer/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-select-otc-and-non-core-assets-to-orifarm/ 2023-08-03 daily 0.5 https://www.takeda.com/science/products/suppliers/ 2023-08-03 daily 0.5 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/hemofilia-o-papel-do-enfermeiro/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/access-to-medicine/atm-patients-partners/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2020/collaboration-with-kanagawa/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/211028-8300/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/vpriv/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/anaplastisches-grobzelliges-lymphom-als-peripheres-t-zell-lymphom/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/improving-health-of-ethnic-minority-women-and-newborns-in-asia/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/takako-ohyabu/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/rare-disease-day-2023/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/effort/disease-and-disability/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/advancing-our-manufacturing-processes-with-a-simple-sketch/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/transparency-disclosures/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2017/20171101_7867/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/elaine-shannon/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/world-vision-2016/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2021/takeda-mexico-lanza-tratamiento-para-pacientes-con-hemofilia-tipo-a/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/our-impact/our-stories/accelerating-next-generation-cell-therapies/ 2023-08-03 daily 0.5 https://www.takeda.com/zh-tw/newsroom/news/2023/0601/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-announces-candidates-for-new-directors/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/costa-saroukos/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/phase-3-spring-study-data-presented-at-eaaci/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/digital-birth-program/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2022/takeda-recognized-as-one-of-japans-most-lgbtq-friendly-companies/ 2023-08-03 daily 0.5 https://www.takeda.com/ro-ro/who-we-are/company-information/building-trust/transparency/2016-archive22/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-its-japan-consumer-health-care-business-unit-to-blackstone/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unf-2016/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/alunbrig/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/wfp-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/biodiversity/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/Cooperation/sil/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/improving-access-to-health-care-in-rural-west-africa/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2023/takeda-promueve-el-dialogo-sobre-digitalizacion-en-el-sector-salud-para-mejorar-la-experiencia-de-pacientes-y-profesionales-sanitarios/ 2023-08-03 daily 0.5 https://www.takeda.com/about/our-company/history/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/pure-earth-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/skit-oi/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2021/vtol/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/giles-platford/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unf-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/newsroom/news-releases/2022/takeda-receives-us-fda-approval-for-prefilled-syringe-presentation-of-takhzyro/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/company/shonanresearch/Cooperation/cockpi-t/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-07/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/u.s.-fda-approves-supplemental-new-drug-application-for-takedas-iclusig-ponatinib-for-adult-patients-with-resistant-or-intolerant-chronic-phase-cml/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-08/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/hodgkin-lymphom/ 2023-08-03 daily 0.5 https://www.takeda.com/da-dk/nordic-rare-disease-summit/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2018/20181031-8012/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/european-commission-ec-approves-livtencitytm-maribavir/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-four-diabetes-products-in-japan-to-teijin-pharma-limited/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/lauren-duprey/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-03/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-04/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-05/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/timely-broad-and-sustainable-access/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/newgrads/guideline/treatment/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/subgroup-analysis-from-phase-3-clinical-trial-supports-efficacy-of-maribavir-over-conventional-therapies-in-transplant-recipients-with-cytomegalovirus-infection/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-06/ 2023-08-03 daily 0.5 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/Reflektioner-fran-Takedas-och-Dagens-Medicins-panelsamtal-om-ADHD/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2023/20230628_8389/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/ipas/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/notice-of-suspension-of-use-of-specific-lots-of-modernas-covid-19-vaccine-in-japan/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-01/ 2023-08-03 daily 0.5 https://www.takeda.com/es-es/Sala-de-prensa/Comunicados-de-prensa/2023/la-web-de-takeda-sobre-enfermedades-lisosomales-%20galardonada-con-los-premios-aspid-y-saniss/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/dei/employee-interview/interview-02/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/gabriele-ricci/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unicef-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/investors/financial-results/2021/fy2021-q2-results-audio2/ 2023-08-03 daily 0.5 https://www.takeda.com/pt-pt/takeda-talks/hemofilia/profilaxia/hemofilia-o-testemunho-de-carlos-mota-sobre-o-antes-de-depois-da-profilaxia/ 2023-08-03 daily 0.5 https://www.takeda.com/fr-fr/que-faisons-nous/pathologies-par-aires-therapeutiques/Therapiesderiveesduplasma/takeda-et-le-plasma/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unicef-2017/ 2023-08-03 daily 0.5 https://www.takeda.com/en-ca/newsroom/news-releases/2023/takeda-presents-real-world-clinical-effectiveness-and-safety-results-of-%20vedolizumab-entyvio-and-ustekinumab-as-first-line-biologic-treatment-for-crohns-disease/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/takedas-response-to-the-new-incident-announced/ 2023-08-03 daily 0.5 https://www.takeda.com/sv-se/our-stories/caring/newsroom-almedalen/Inspelningar-av-Takeda-seminarierna-2023-finns-tillgangliga/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-giving/programs/unicef-2018/ 2023-08-03 daily 0.5 https://www.takeda.com/en-us/what-we-do/areas-of-focus/rare-diseases/reduce-time-to-diagnosis-improve-access-to-care/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/tak-123-1001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210201-8235/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210224-8241/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/andrew-plump/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP607-202/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200908-8197/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/takeda-recognized-as-one-of-japans-most-lgbtq-friendly-companies/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/funding/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/supporting-recovery-in-tohoku/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2023/impacta-enfermedad-inflamatoria-intestinal-a-la-salud-mental/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-625-3002/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/our-company/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-625-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2022/Internship/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210331-8252/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/joicfp-2017/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210331-8253/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2021/modernatak-919/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-667-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-620-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/teresa-bitetti/ 2023-08-03 daily 0.5 https://www.takeda.com/about/our-company/history/corporate-symbols/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/2023-event-report-1/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201207-8218/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-13en/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/masami-iijima/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/plan-international-2017/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210201-8234/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-664-3002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-925-1003/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-11/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-10/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-01/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Azilsartan-3004/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210129-8233/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200807-8192/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2018/tigenix-and-takeda-announce-alofisel-receives-approval-in-europe/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP634-301/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/elaine-shannon/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-438ODT-1001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t/TA/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210924-8291/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-04/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Ponatinib-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-continues-divestiture-strategy-with-sale-of-select-otc-and-non-core-assets-in-europe-to-orifarm-for-up-to-approximately-$670m-usd/ 2023-08-03 daily 0.5 https://www.takeda.com/about/our-company/takeda-life-theater/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/ramona-sequeira/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210401-8255/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210402-8256/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16010/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16011/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210401-8254/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/investors/financial-results/2021/fy2021-q1-results-audio/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/ipas/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unicef-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-981-1502/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unicef-2018/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/koki-sato/ 2023-08-03 daily 0.5 https://www.takeda.com/ro-ro/privacy-policy/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210428-8259/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/AP32788-15-101/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Brigatinib-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-079-1006/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/milano-furuta/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/pure-earth-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unicef-2017/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/ian-clark/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-019-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Brigatinib-2002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-102-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-919-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-981-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/thomas-wozniewski/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/alofisel/richtlijn-voor-chirurgen-betreffende-alofisel-wijze-van-toedienen-instructievideo/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210316-8248/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/event-report-4/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/faq/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/improving-access-to-health-care-in-rural-west-africa/ 2023-08-03 daily 0.5 https://www.takeda.com/nl-nl/zorgverleners/ondersteunend-materiaal/hyqvia/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210428-8258/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210316-8249/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210128-8232/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210127-8231/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP615-301/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201201-8216/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-079-1004/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201201-8215/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/advancing-leadership-of-women-and-girls/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-103-1001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-771-3005/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/prostatakarzinom/therapie/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/takeda-chair/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Darvadstrocel-3004/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-771-3004/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210310-8244/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP615-302/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/christophe-weber/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Niraparib-213831/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Cabozantinib-2003/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-09/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220413_8322/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-to-divest-otc-and-select-non-core-assets-in-asia-pacific-to-celltrion-for-up-to-$278-million-usd/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-771-3002/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200824-8193/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-08/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Darvadstrocel-3002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-931-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-receives-approval-to-manufacture-and-market-alofisel-darvadstrocel-in-japan-for-treatment-of-complex-perianal-fistulas-in-patients-with-non-active-or-mildly-active-luminal-crohns-disease/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Cabozantinib-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/michel-orsinger/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/city-cancer-challenge/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Niraparib-1001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-governance/governance-structure/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2017/Maverick-Therapeutics-and-Takeda-Announce-Five-year-Collaboration-to-Advance/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200826-8194/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-659-C34007/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-10/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201029-8211/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/yoshiaki-fujimori/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201113-8213/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN0002SC-3030/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200916-8200/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-672-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/seed-global-health-2018/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t/confirmation/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/careerinterview/interview-11/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/expanding-neglected-patient-access/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/lauren-duprey/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-861-1001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220419_8324/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201208-8220/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/jean-luc-butel/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/event-report-1/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/erkrankungen-des-verdauungssystems/saurebedingte-erkrankungen/magen--bzw.-zwolffingerdarmgeschwur/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/event-report-3/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP611-201/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/event-report-2/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-906-2002/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/steven-gillis/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/our-company/history/corporate-symbols/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200918-8202/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/john-maraganore/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/engaging-our-people/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210125-8230/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201208-8219/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SGN35-C25004/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/CONTACT-02/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-743-5007/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-662-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16027/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/building-a-mother-focused-health-system-in-india/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/koji-hatsukawa/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/our-company/corporate-philosophy/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/marcello-agosti/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2015/20150727_7062/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/olivier-bohuon/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-743-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/prostatakarzinom/berufsverband/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/board-of-directors/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/iaea-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unf-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unf-2016/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t/platform/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-935-1004/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/takako-ohyabu/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201221-8225/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210524-8269/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-08/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-07/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-341-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-925-2002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-06/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-05/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200916-8199/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/281102/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-04/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/access-to-health-fund-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SGN35-C25003/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-03/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201221-8223/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/innovation-and-elimination-of-ntds/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-573-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-02/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/activities/activity-01/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/products/manufacturing/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/plan-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN0002-3029/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/takeda-ma/interview/interview-01/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs-in-action/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/last-mile-health/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/prostatakarzinom/fachgesellschaft---ogu/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Pevonedistat-1012/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN0002-3025/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN0002-3024/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200508-8152/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/erkrankungen-des-verdauungssystems/saurebedingte-erkrankungen/refluxkrankheit/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200804-8191/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/yoshihiro-nakagawa/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201009-8204/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-633-3008/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201009-8205/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-788-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16014/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-994-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2022/takeda-announces-new-assignments-of-directors/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP633-307/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/save-the-children-2016/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP633-306/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16019/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210326-8251/ 2023-08-03 daily 0.5 https://www.takeda.com/de-at/patients/onkologie/prostatakarzinom/krankheitsbild/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-994-1504/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unfpa-2021/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unfpa-2022/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/giles-platford/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2022/hae/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2020/takeda-agrees-to-divest-select-otc-and-non-core-assets-in-latin-america-to-hypera-pharma-for-$825-million-usd/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-935-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Pevonedistat-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Niraparib-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-935-3002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-019-1501/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Niraparib-2002/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2015/20150420_6965/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201216-8222/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-935-3003/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/kimberly-reed/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2018/20180405_7953/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-931-1002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP643-302/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-664-3001/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20201014-8207/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/SHP643-303/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/2022-event-report-1/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Vedolizumab-3035/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/event-report/2022-event-report-2/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-03/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-02/ 2023-08-03 daily 0.5 https://www.takeda.com/newsroom/newsreleases/2021/takeda-to-divest-four-diabetes-products-in-japan-to-teijin-pharma-limited/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/Vedolizumab-3039/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/mwana-lugogo/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-01/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/gabriele-ricci/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-861-2002/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-08/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/miki-tsusaka/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/costa-saroukos/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-861-2003/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-06/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220221_8317/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-228-C31008/ 2023-08-03 daily 0.5 https://www.takeda.com/about/leadership/emiko-higashi/ 2023-08-03 daily 0.5 https://www.takeda.com/es-mx/prensa/2023/son-clave-alianzas-en-salud-publica-ante-aumento-enfermedades-por-cambio-climatico-y-urbanizacion/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-04/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-861-2001/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/TAK-788-1003/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/serious-fun-2019/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/julie-kim/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/efpia/2020/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/world-vision-2016/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/ethics-disclosures/efpia/2021/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/clinical-trial/MLN9708-C16021/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/recruitment/oncology/employee/introduction-09/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/kimberly-reed/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/supporting-the-people-who-fight-cancer/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/jean-luc-butel/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/steven-gillis/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200611-8170/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/our-company/takeda-life-theater/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/ian-clark/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220629_8337/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/wfp-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2022/discussion-paper/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2017/20170112_7658/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/access-to-medicine/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2022/20220427_8326/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t_scr/confirmation/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210521-8267/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2021/20210226-8242/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/herhealth/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/announcements/2021/PatientJourney/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/digital-birth-program/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/masami-iijima/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/michel-orsinger/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/emiko-higashi/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/miki-tsusaka/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/unfpa-2020/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200302-8135/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/newsroom/newsreleases/2020/20200424-8150/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/yoshiaki-fujimori/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/olivier-bohuon/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/koji-hatsukawa/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/leadership/john-maraganore/ 2023-08-03 daily 0.5 https://www.takeda.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/purpose-led-sustainability-governance/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/takeda-initiative-1/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-giving/programs/takeda-initiative-2/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/access-to-medicine/atm-patients-partners/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/our-progress-towards-environmental-sustainability/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t_scr/application-form/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/purpose-led-sustainability-governance/materiality/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/patients/ 2023-08-03 daily 0.5 https://www.takeda.com/ja-jp/who-we-are/research/open-innovation/cockpi-t/application-form/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/decarbonizing/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/waste/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/positions/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/timely-broad-and-sustainable-access/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/products/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/water/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/biodiversity/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/ethics-disclosures/ethics/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/science/products/suppliers/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/engaging-our-people/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/purpose-led-sustainability-governance/ 2023-08-03 daily 0.5 https://www.takeda.com/jp/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/responsibly-translate-science/ 2023-08-03 daily 0.5